Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Miguel Martín
Based on 109 articles published since 2008
||||
Expertise Level
The expertise of Miguel Martín ranks in the
  • Top 0.0074%
  • ... of 257,180 published authors worldwide on Breast Neoplasms
  • ... from 2008 through 2018
  • ... based on contributions to 109 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Martín, Miguel   ·   Martin, Miguel
Work Locations
Details
Most likely:    Hospital General Gregorio Maranon      
2018
  • From the University of Texas M.D. Anderson Cancer Center, Houston (J.K.L.), and the Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas (J.L.B.) - both in Texas · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (H.S.R.), and Pfizer (R.G.W.Q., D.M., I.C.T., A.L.H.), San Francisco, University of California, Los Angeles, Los Angeles (S.A.H.), and Kaiser Permanente, Northern California, Vallejo (L.F.) - all in California · the Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technische Universität München (J.E.), and Interdisziplinäres Onkologisches Zentrum München (W.E.) - both in Munich, Germany · Institut Paoli-Calmettes, Marseille (A.G.), and Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulouse (H.R.) - both in France · Seoul National University Hospital (K.-H.L.) and Samsung Medical Center (Y.-H.I.) - both in Seoul, South Korea · Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel (R.Y.) · Banner M.D. Anderson Cancer Center, Gilbert, AZ (L.A.M.) · and Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Oncología, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid (M.M.). · Pubmed 30110579
  • Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Via Suor Niccolina 20, Prato 59100, Italy. Electronic address: · CHU Sart Tilman Liège and Liège University, Avenue de L'Hôpital 1, 4000 Liège, Belgium. Electronic address: · Instituto Nacional del Cáncer, Avda Profesor Zañartu 1010, Independencia, Santiago, Región Metropolitana, Chile. Electronic address: · University of Antwerp, Prinsstraat 13, 2000 Antwerpen, Belgium. Electronic address: · University of Kansas Cancer Center, 1000 E 101st Terrace, Kansas City, MO 64131, USA. Electronic address: · Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Via Suor Niccolina 20, Prato 59100, Italy. Electronic address: · AstraZeneca, da Vinci Building, Melbourn Science Park, Melbourn, Royston, Herts, SG8 6HB, UK. Electronic address: · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CiberOnc, GEICAM, Madrid 28007, Spain. Electronic address: · Pubmed 29324303
  • Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029, Madrid, Spain. · Gregorio Marañón Health Research Institute (IISGM), Universidad Complutense, 28007, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario Ramón y Cajal, 28034, Madrid, Spain. · Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, CB1 8RN, UK. · Department of Pediatric Hemato-Oncology, Hospital Universitario La Paz, 28046, Madrid, Spain. · Pediatric Solid Tumor Laboratory, Human Genetic Department, Research Institute of Rare Diseases, Instituto de Salud Carlos III, 28220, Majadahonda, Spain. · Department of Pediatric Cardiology, Hospital Universitario La Paz, 28046, Madrid, Spain. · Medical Oncology Service, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, 28040, Madrid, Spain. · Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain. · Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, CB1 8RN, UK. · Department of Pediatrics, Universidad de Navarra, University Clinic of Navarra, 31008, Pamplona, Spain. · Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029, Madrid, Spain. · Pubmed 28913729
2017
  • Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), CiberOnc, Madrid, Spain. · Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), Universidad Complutense, CiberOnc, GEICAM, Madrid, Spain. · Pubmed 28758424
  • a Medical Oncology Department , Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) , Madrid , Spain. · b Medical Oncology Department , Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CiberOnc , Madrid , Spain. · c Instituto de Investigación Sanitaria Gregorio Maranon (IiSGM), Universidad Complutense, CiberOnc, GEICAM , Madrid , Spain. · Pubmed 28649882
  • Instituto de Investigación Sanitaria Gregorio Marañón, Grupo Español de Investigación en Cáncer de Mama (GEICAM), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Universidad Complutense, Madrid, Spain. Electronic address: · Texas Oncology, Houston, TX, USA. · Rigshospitalet, Copenhagen, Denmark. · Institut Gustave Roussy, Villejuif, France. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Aichi Cancer Center, Chikusa-ku, Nagoya, Japan. · Luisenkrankenhaus, German Breast Group Forschungs GmbH, Düsseldorf, Neulsenburg, Germany. · BC Cancer Agency, Vancouver, BC, Canada. · Guy's and St Thomas' Hospital National Health Service Foundation Trust and Biomedical Research Centre, King's College, London, UK. · Pontifical Catholic University of Rio Grande do Sul School of Medicine, Porto Alegre, Brazil. · Department of Surgery and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria. · Daily Chemotherapy Hospital, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia. · Virginia Cancer Specialists, Arlington, VA, USA. · University Hospital for Tumors, University Hospital Center "Sestre milosrdnice", Zagreb, Croatia. · Ege University Faculty of Medicine, Izmir, Turkey. · Auckland Hospital, Auckland, New Zealand. · Oncology Department, Hospital Universitario Virgen del Rocio, Seville, Spain. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Department of Oncology, Lillebaelt Hospital, Vejle, Denmark. · Oncology Institute of Vilnius University, Vilnius, Lithuania. · Breast Oncology, Saitama Cancer Center, Kita-Adachi, Japan. · Oncologianova GmbH, Recklinghausen, Germany. · Department of Medical Oncology, Amphia Hospital, Breda, Netherlands. · Department of Oncology, Christie Hospital Manchester, Manchester, UK. · Breastlink Medical Group Inc, Santa Ana, CA, USA. · University of Alberta, Department of Oncology, Cross Cancer Institute, Edmonton, AB, Canada. · Puma Biotechnology Inc, Los Angeles, CA, USA. · International Drug Development Institute, Louvain-la-Neuve, Belgium. · Breast Cancer Research Centre-Western Australia, Perth, WA, Australia; Curtin University, Perth, WA, Australia. · Pubmed 29146401
  • Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain, on behalf of GEICAM (Spanish Breast Cancer Group), Spain. · Oncology Department, Hospital Universitario Virgen de la Salud, Toledo, Spain. · Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Oncology Department, Onkologikoa, San Sebastián, Spain. · Oncology Department, Hospital General Universitario Morales Messeguer, Murcia, Spain. · Oncology Department, Corporación Sanitaria Parc Taulí, Barcelona, Spain. · Oncology Department, Complejo Hospitalario de Jaén, Jaén, Spain. · Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Oncology Department, Complejo Hospitalario Universitario de la Coruña, La Coruña, Spain. · Oncology Department, Hospital Universitario la Paz, Madrid, Spain. · Medical Oncology Department, Hospital de Santa Creu i Sant Pau, Institut de Recerca IIB Sant Pau, Barcelona, Spain. · Oncology Department, Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife, Spain. · Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain. · Oncology Department, Hospital Clinic i Provincial, Barcelona, Spain. · GEICAM headquarters, Madrid, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 28701571
  • Department of Medical Oncology, Hospital Clínic i Provincial, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medical Oncology, Valencia University Hospital, Valencia, Spain. · University of Edinburgh Cancer, Research UK Centre, Edinburgh. · Department of Biochemistry, University of Otago, Dunedin, New Zealand. · Department of Medical Oncology, A Coruña University Hospital Complex, A Coruña, Spain. · Department of Medical Oncology, Hospital del Mar Medical Research Institute-IMIM and Pompeu Fabra University, Barcelona, Spain. · Department of Medical Oncology, Biomedical Research Institute-IMIBIC, Reina Sofía Hospital Complex, Córdoba, Spain. · Department of Medical Oncology, Consorci Sanitari de Terrassa, Barcelona, Spain. · Department of Medical Oncology, Virgen de la Salud Hospital, Toledo, Spain. · Department of Medical Oncology, Jaén Hospital Complex, Jaen, Spain. · Department of Medical Oncology, Onkologikoa, Donostia, Spain. · Department of Medical Oncology, Hospital Clínic i Provincial, Barcelona, Spain. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina. · Department of Medical Oncology, Virgen de la Victoria University Hospital, Málaga, Spain. · GEICAM (Spanish Breast Cancer Research Group), Madrid, Spain. · Academic Department of Biochemistry, Royal Marsden Foundation Trust, London, United Kingdom. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Department of Genetics, University of North Carolina, Chapel Hill, North Carolina. · Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina. · Pubmed 27903675
  • Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid, Spain. · Spanish Breast Cancer Research Group (GEICAM), San Sebastian de los Reyes, Spain. · Instituto de Salud Carlos III, Madrid, Spain. · Servicio de Oncología Médica, Instituto Valenciano de Oncología, Valencia, Spain. · Servicio de Oncología Médica, Hospital Universitari i Politècnic La Fe, Valencia, Spain. · Servicio de Oncología Médica, Hospital de Basurto-Osakidetza, Bilbao, Spain. · Servicio de Oncología Médica, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain. · Servicio de Oncología Médica, Hospital Lozano Blesa, Zaragoza, Spain. · Servicio de Oncología Médica, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Servicio de Oncología Médica, Hospital Arnau de Vilanova, Valencia, Spain. · Sección de Oncología Médica, Complejo Universitario de Albacete, Albacete, Spain. · Servicio de Oncología Médica, Servicio de Oncología Médica, Hospital Mútua de Terrassa, Barcelona, Spain. · Servicio de Oncología Médica, Hospital de Sabadell-Consorcio Sanitario Parc Taulì de Sabadell, Barcelona, Spain. · Servicio de Oncología Médica, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Servicio de Oncología Médica, Hospital Universitario Sant Joan, Alicante, Spain. · Servicio de Oncología Médica, Hospital General Universitario de Elche, Elche, Spain. · Servicio de Oncología Médica, Hospital de Sant Pau, Barcelona, Spain. · Unitat de Consell Genetic, Institut Oncologic del Valles, Terrasa, Spain. · Unidad de Oncología, Hospital Universitario Fundación Alcorcón, Alcorcon, Madrid, Spain. · Pubmed 28985233
  • Genolier Breast Center, Clinic of Genolier, Route du Muids 3, 1272 Genolier, Switzerland. Electronic address: · Department of Senology, National Cancer Institute G. Pascale Foundation, Via Mariano Semmola, 80131 Naples, Italy. · School of Cancer Sciences, University of Birmingham, Vincent Drive, Edgbaston, B15 2TT Birmingham, United Kingdom. · Department of Surgery, Instituto Nacional de Cancerología, Av. San Fernando No. 22, Col. Sección XVI Delegación Tlalpan, 14080 Mexico City, Mexico. · División Ginecologia y Mastologia, Hospital Dr. I. Pirovano, Av Monroe 3555, 1428 Buenos Aires, Argentina. · Department of Oncoradiology, Uzsoki Teaching Hospital, Uzsoki u. 29-41, 1145 Budapest, Hungary. · Department of Oncology, Sahlgrenska Academy and University Hospital, Per Dubbsgatan 15, 413 45 Gothenburg, Sweden; Department of Oncology/Pathology, Karolinska Institutet, Karolinska Univ Hospital, Z1:00, 171 76 Stockholm, Sweden. · University of Florida Health Cancer Center at Orlando Health, 1400 S. Orange Avenue, 32806 Orlando, FL, USA. · Department of Surgery, Athens University Medical School, Iassiou Street 8, 11521 Athens, Greece. · Multidisciplinary Breast Centre and Gynaecological Oncology, UZ Leuven, Herestraat 49, 3000 Leuven, Belgium. · Department of Radiosurgery, Russian Cancer Research Center, 23 Kashirskoye Shosse, Moscow, Russia. · Department of Surgery, Institut Curie-Université Versailles-Saint-Quentin, 35 rue Dailly, 92220 Paris-Saint-Cloud, France. · Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. · Medical Affairs, Genomic Health, Quai du Sujet 10, Stockholm, Sweden. · International, Genomic Health, Quai du Sujet 10, Geneva, Switzerland. · Department of Gynaecology, Martin-Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany. · Instituto de Investigación Sanitaria Hospital Gregorio Marañón, Universidad Complutense, c/Dr Esquerdo 46, 28007 Madrid, Spain. · Pubmed 28441617
  • Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain. · Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy. · Medical Oncology Deparment, Arnau de Vilanova de Lleida Universitary Hospital, Lleida, Spain. · Medical Oncology Department, Reina Sofía University Hospital, Cordoba, Spain. · Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Universidad Complutense, Madrid, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Medical Oncology Department, Quirón Hospital, Madrid, Spain. · Master of Breast Pathology, University of Barcelona, Barcelona, Spain. · Pathology Department, Fundación Jiménez Díaz Health Research Institute (IIS-FJD), Madrid, Spain. · Medical Oncology Department, Doce de Octubre Hospital, Madrid, Spain. · Medical Oncology Department, Hospital del Mar, Barcelona, Spain. · Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain. · Medical Oncology Department, Mutua de Terrassa Hospital, Barcelona, Spain. · Spanish Breast Cancer Research Group Grupo Español de Investigación en Cáncer de Mama (GEICAM), Madrid, Spain. · Pubmed 28423537
  • Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), Madrid, Spain; Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain. · Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain; Health Research Institute Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Dpto. Ciencias Sociales de la Actividad Física y del Ocio, Facultad de Ciencias de la Actividad Física y el Deporte, Universidad Politécnica, Madrid, Spain. · Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain. · Medical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain. · Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain. · Medical Oncology Unit, Complejo Hospitalario Universitario, A Coruña, Spain. · Hematology-Oncology Department, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Valencia, Spain. · Medical Oncology Hospital Clínic and Translational Genomics and Targeted Therapeutics in Solid Tumors, Barcelona, Spain. · Medical Oncology Unit, Centro Oncológico de Galicia, A Coruña, Spain. · Medical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain. · Medical Oncology Unit, Hospital Universitario Fundación Alcorcón, Universidad Rey Juan Carlos, Madrid, Spain. · Medical Oncology Unit, Instituto de Investigación Sanitaria Aragón, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Spanish Breast Cancer Research Group (GEICAM) Headquarters, Madrid, Spain. · Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain. · Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), Madrid, Spain; Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain. Electronic address: · Pubmed 28057355
  • Hospital General Universitario Gregorio Marañon, Madrid, Spain. · Hospital Clínico San Carlos, Madrid, Spain. · Hospital Universitario Infanta Cristina, Parla, Madrid, Spain. · Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), Madrid, Spain. · Hospital General Universitario Gregorio Marañon, Madrid, Spain. · Pubmed 28040858
  • University of Kansas Medical Center, Westwood, Kansas. · Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain. · University of Kansas Medical Center, Westwood, Kansas. · Medical Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Laboratory of Translational Oncology. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Oncology Department, Hospital Clínico, Valladolid, Spain. · Department of Oncology, Ramon y Cajal University Hospital, Madrid, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. · Department of Pathology & Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. · Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Pubmed 27301700
2016
  • Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, C/Dr Esquerdo 46, Madrid 28009, Spain. Electronic address: · Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, C/Dr Esquerdo 46, Madrid 28009, Spain. Electronic address: · Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, C/Dr Esquerdo 46, Madrid 28009, Spain. Electronic address: · Pubmed 27326977
  • From the Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Pubmed 27249772
  • Dept. of Hematology and Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, "Rio Hortega Project in research training" (CM12/00264), Spain. Electronic address: · Dept. of Hematology and Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Spain. · Dept. of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain. · Dept. of Medical Oncology, Hospital Del Mar, Barcelona, Spain. · Dept. of Hematology and Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Spain. Electronic address: · Pubmed 26318092
  • From the Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at the University of California, Los Angeles, Santa Monica (R.S.F., D.J.S.), the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco (H.S.R.), and Pfizer, La Jolla (E.G., D.R.L., S.R.) - all in California · Hospital Gregorio Maranon, Universidad Complutense, Madrid (M.M.) · U.S. Oncology Research, The Woodlands, TX (S.J.) · Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.) · British Columbia Cancer Agency, Vancouver, Canada (K.G.) · Brustzentrum der Universität München (LMU), Munich, Germany (N.H.) · State Budget Medical Institution Republican Clinical Oncology, Ufa, Russia (O.N.L.) · All-Ireland Cooperative Oncology Research Group, Dublin (J.M.W.) · M.D. Anderson Cancer Center, University of Texas, Houston (S.M.) · and Institut Curie, Paris (V.D.). · Pubmed 27959613
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Hospital General Universitario and Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Hopital Sant Louis, Paris, France. · Pharma-Mar, Clinical R&D, Colmenar Viejo, Madrid, Spain. · Institut Gustave Roussy, Villejuif, France. · Pubmed 27266804
  • Department of Medical Oncology, Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutente de Madrid, Calle Maiquez 7, Madrid, Spain. · Sividon Diagnostics GmbH, Cologne, Germany. · Department of Medical Oncology, Valencian Institute of Oncology (IVO), Valencia, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medical Oncology, A Coruña University Hospital Complex, A Coruña, Spain. · Solid Tumor Molecular Diagnostics Laboratory, ARUP Laboratories, Utah, USA. · Department of Medical Oncology, Virgen del Rocio University Hospital, Seville, Spain. · Department of Medical Oncology, Salamanca University Hospital-IBSAL, Salamanca, Spain. · Department of Medical Oncology, Donostia University Hospital, Donostia, Spain. · Department of Medical Oncology, Parc Tauli University Hospital, Sabadell, Spain. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Department of Genetics, University of North Carolina, Chapel Hill, NC, USA. · Department of Pathology & Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA. · Spanish Breast Cancer Research Group (GEICAM), Madrid, Spain. · Department of Medical Oncology, Elche University General Hospital, Elche, Spain. · Pubmed 26909792
  • Breast Cancer Research Centre-Western Australia and Curtin University, Perth, WA, Australia. Electronic address: · Institut Gustave Roussy, Villejuif, France. · Texas Oncology, Houston, TX, USA. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Aichi Cancer Center, Chikusa-ku, Nagoya, Japan. · Auckland Hospital, Auckland, New Zealand. · Virginia Cancer Specialists, The US Oncology Network, Fairfax, VA, USA. · University Hospital For Tumors, University Hospital Center "Sestre Milosrdnice", Zagreb, Croatia. · Ege University Faculty of Medicine, Izmir, Turkey. · Luisenkrankenhaus, German Breast Group Forschungs GmbH, Düsseldorf, Neu-lsenburg, Germany. · Rigshospitalet, Copenhagen, Denmark. · BC Cancer Agency, Vancouver, BC, Canada. · Guy's and St Thomas' NHS Foundation Trust and Biomedical Research Centre, King's College London, London, UK. · Pontifical Catholic University of Rio Grande do Sul School of Medicine, Porto Alegre, Brazil. · Department of Surgery and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria. · International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium. · Alabama Oncology, Birmingham, AL, USA. · Northwest Cancer Specialists, Vancouver, VA, USA. · Utah Cancer Specialists, Salt Lake City, UT, USA. · National Hospital Organization Osaka National Hospital, Chuou-ku, Osaka, Japan. · Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Instituto Valenciano de Oncologia, València, Spain. · Hematology Oncology Associates of Treasure Coast, Port Saint Lucie, FL, USA. · South Texas Oncology and Hematology, San Antonio, TX, USA. · Magna Graecia University, Catanzaro, Italy. · Puma Biotechnology, Los Angeles, CA, USA. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, Madrid, Spain. · Pubmed 26874901
  • University of Arizona Cancer Center, Tucson, AZ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Centre Hospitalier Universitaire Brugmann, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Research UK Experimental Cancer Medicine Centres, St James's University Hospital, Leeds, UK. · Weston Park Hospital, University of Sheffield, Sheffield, UK. · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. · Center for Comprehensive Gynecology Clinic, Mannheim, Germany. · National Cancer Center Hospital, Tokyo, Japan. · Instituto de Investigación Sanitaria General Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Cross Cancer Institute, Edmonton, AB, Canada. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Lancaster Urology, Lancaster, PA, USA. · Urology Associates, Christchurch, New Zealand. · The Urology Center of Colorado, Denver, CO, USA. · Sarah Cannon Research Institute, Nashville, TN, USA. · Amgen Inc., Thousand Oaks, CA, USA. · Pubmed 26335402
  • Michael F. Press, Denice D. Tsao-Wei, Yanling Ma, Ivonne Villalobos, and Anaamika Campeau, University of Southern California Norris Comprehensive Cancer Center · Dennis J. Slamon, Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA · Nicholas Robert, Virginia Cancer Specialists/US Oncology Research Network, Fairfax, VA · Vicente Valero, The University of Texas MD Anderson Cancer Center, Houston, TX · Guido Sauter and Martina Mirlacher, University of Hamburg, Hamburg · Wolfgang Eiermann, Frauenklinik vom Roten Kreuz, Munich, Germany · Marc Buyse, Hélène Fourmanoir, and Emmanuel Quinaux, International Drug Development Institute, Louvain-la-Neuve, Belgium · Tadeusz Pienkowski, Postgraduate Medical Education Center, Warsaw, Poland · John Crown, Irish Cooperative Onoclogy Research Group, St Vincent's University Hospital, Dublin, Ireland · Miguel Martin, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain · John R. Mackey, University of Alberta · Mary-Ann Lindsay, Cancer International Research Group/Translational Research in Oncology, Edmonton, Alberta, Canada · and Valerie Bee, Cancer International Research Group/Translational Research in Oncology, Paris, France. · Pubmed 27573653
  • Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, Madrid, Spain. · Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, Madrid, Spain. · Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, Madrid, Spain. · Medical Genetics Unit, Sistemas Genómicos SA, Valencia, Spain. · Medical Oncology Service, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid, Spain. · Instituto Nacional de Enfermedades Neoplásicas (I.N.E.N.), Lima, Peru. · Pubmed 27083178
  • Center for Oncology and Hematology, Wilhelminen Hospital, Vienna, Austria. Electronic address: · Massachusetts General Hospital Biostatistics Center, Boston, MA, USA. Electronic address: · Royal Marsden Hospital, London, UK. Electronic address: · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. Electronic address: · Rigshospitalet, DBCG Secretariat, Copenhagen, Denmark. Electronic address: · Mater Hospital, North Sydney, NSW, Australia. Electronic address: · University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Centre GF Leclerc, Dijon, France. Electronic address: · Northwestern University, Chicago, IL, USA. Electronic address: · Hospital Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. Electronic address: · Massachusetts General Hospital, Boston, MA, USA. Electronic address: · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada. Electronic address: · Arizona Oncology, US Oncology, Sedona, AZ, USA. Electronic address: · GlaxoSmithKline, Collegeville, PA, USA. Electronic address: · Massachusetts General Hospital Biostatistics Center, Boston, MA, USA. Electronic address: · Massachusetts General Hospital, Boston, MA, USA. Electronic address: · Pubmed 26829011
  • Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Dr Esquerdo 46, 28007 Madrid, Spain. Electronic address: · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Dr Esquerdo 46, 28007 Madrid, Spain. · Pubmed 26617201
2015
  • Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Pubmed 26101243
  • Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Dr Esquerdo 46, Madrid, 28007, Spain. · Pubmed 26067995
  • Karen A. Gelmon, David G. Huntsman, and Samuel Aparicio, British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver · Susan L. Ellard, British Columbia Cancer Agency, Cancer Centre for the Southern Interior, Kelowna, British Columbia · Julie Lemieux, Centre Hospitalier Affilié Hopital Du St Sacrement, Quebec City, Quebec · Lois E. Shepherd, Dora Nomikos, Judith-Anne W. Chapman, and Wendy R. Parulekar, NCIC Clinical Trials Group, Queen's University, Kingston · Susan Dent, Ottawa Health Research Institute, Ottawa · Kathleen I. Pritchard, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto · Timothy J. Whelan, Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario · Katia Tonkin, Cross Cancer Institute, Edmonton, Alberta, Canada · Frances M. Boyle, Patricia Ritchie Centre for Cancer Care and Research, Mater Hospital, North Sydney, New South Wales, Australia · Bella Kaufman, Sheba Medical Centre, Tel Hashomer · Shulamith Rizel, Rabin Medical Center, Petach Tikva, Israel · Alexey Manikhas, City Clinical Oncological Dispensery, St Petersburg · Sergei Tjulandin, Russian Cancer Research Center, Moscow · Rustem Khasanov, Clinical Oncology Dispensary, Kazan, Russia · Angelo Di Leo, Sandro Pitgliani Medical Oncology Unit, Prato, Italy · Miguel Martin, Servicio Oncologia Hospital Gregorio Marañon, Madrid, Spain · Lee S. Schwartzberg, West Clinic, Memphis, TN · Arnd Nusch, Praxis, Velbert, Germany · Robert E. Coleman, Weston Park Hospital, Cancer Research Centre, Sheffield, United Kingdom · Hirofumi Mukai, National Cancer Center Hospital East, Kashiwa-shi, Japan · Anne P. Connor, GlaxoSmithKline, Collegeville, PA · and Sergio L. Santillana, GlaxoSmithKline, Rio de Janeiro, Brazil. · Pubmed 25779558
  • Mater Hospital, Sydney, Australia. Electronic address: · Royal Marsden Hospital, London, UK. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, United States. · Rigshospitalet, DBCG Secretariat, Copenhagen, Denmark. · UT MD Anderson Cancer Center, Houston, TX, United States. · Centre GF Leclerc, Dijon, France. · Northwestern University, Chicago, IL, United States. · Hospital Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Massachusetts General Hospital, Boston, MA, United States. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Canada. · Arizona Oncology, US Oncology, Sedona, AZ, United States. · GlaxoSmithKline, Collegeville, PA, United States; GlaxoSmithKline, Uxbridge, UK. · Pubmed 25752740
  • Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain; · Hospital Universitario Ramón y Cajal, Madrid, Spain; · Centro Oncológico Galicia, A Coruña, Spain; · Complejo Hospitalario A Coruña (CHUAC), A Coruña, Spain; · Hospital Clínico Universitario de Valencia, Valencia, Spain; · Hospital Universitario La Paz, Madrid, Spain; · Hospital Clinic de Barcelona, Barcelona, Spain; · GEICAM (Spanish Breast Cancer Group), San Sebastián de los Reyes, Madrid, Spain; · Hospital Clínico San Carlos, Madrid, Spain; · Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain; · Hospital Universitario Virgen del Rocío, Sevilla, Spain; · Hospital General Yagüe, Burgos, Spain; · Hospital Virgen de la Salud, Toledo, Spain; · Hospital General De Hospitalet, Hospitalet de Llobregat, Barcelona, Spain; · Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)-Hospital Universitario Reina Sofía, Universidad de Córdoba, Córdoba, Spain; · Complejo Hospitalario de Pontevedra, Pontevedra, Spain. · Pubmed 25601966
  • John R. Mackey, Cross Cancer Institute · Francois Thireau and Helena Fung, Translational Research in Oncology, Edmonton · Marc Webster, Tom Baker Cancer Centre, Calgary, Alberta · Karen A. Gelmon, British Columbia Cancer Agency, Vancouver, British Columbia · Sunil Verma, Sunnybrook Health Sciences Center · Lorinda Simms, Eli Lilly, Toronto, Ontario, Canada · Manuel Ramos-Vazquez, Centro Oncológico de Galicia "José Antonio Quiroga y Piñeiro," A Coruña · Miguel Martin, Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutense, Madrid, Spain · Oleg Lipatov, Republican Clinical Oncology Dispensary, Bashkortostan Republic Ministry of Health, Ufa · Dmitriy Krasnozhon, Leningrad Regional Oncology Dispensary, Leningrad · Vladimir Semiglazov, Institute of Oncology N.N. Petrov · Alexey Manikhas, City Clinical Oncology Dispensary, St Petersburg · Vera Gorbunova, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia · Nicole McCarthy, ICON Cancer Care Wesley, Brisbane, Queensland, Australia · Gottfried E. Konecny, University of California Los Angeles, Los Angeles, CA · Roberto Hegg, Hospital Pérola Byigton Centro de Referência da Saúde da Mulher, Sao Paulo, Brazil · Dany Abi Gerges, Middle East Institute of Health, Bsalim, Lebanon · Marc Buyse, International Drug Development Institute, Louvain-la-Neuve, Belgium · and Ayman Ibrahim, ImClone Systems, Bridgewater, NJ. · Pubmed 25185099
  • Cancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Cancer Epidemiology Research Group, IIS Puerta de Hierro (IDIPHIM), Majadahonda, Madrid, Spain. · Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain; Medical Oncology Unit, Instituto De Investigación Sanitaria Gregorio Marañón/ Universidad Complutense, Madrid, Spain. · Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain. · Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain. · Medical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain. · Medical Oncology Unit, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Medical Oncology Unit, Complejo Hospitalario de Jaén, Jaén, Spain. · Medical Oncology Unit, Centro Oncológico de Galicia, A Coruña, Spain. · Medical Oncology Unit, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Medical Oncology Unit, Hospital Clinic I Provincial, Barcelona, Spain. · Medical Oncology Unit, Hospital Clínico, Valencia, Spain. · Medical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain. · Medical Oncology Unit, Fundación Hospitalaria de Alcorcón, Alcorcón, Spain. · Medical Oncology Unit, Hospital Virgen de la Salud, Toledo, Spain. · Start-up Unit, Spanish Breast Cancer Research Group (GEICAM) Headquarters, San Sebastián De Los Reyes, Madrid, Spain. · Medical Oncology Unit, Instituto De Investigación Sanitaria Gregorio Marañón/ Universidad Complutense, Madrid, Spain. · Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Epidemiology Department, Universidad Miguel Hernandez, Sant Joan d'Alacant, Spain. · Pubmed 25978407
  • Center for Oncology and Hematology, Wilhelminen Hospital, Montleartstrasse 37, Vienna, 1160, Austria. · Massachusetts General Hospital Biostatistics Center, 50 Staniford Street, Boston, MA, 02478, USA. · Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, 3410 Worth Street, Dallas, TX, 75246, USA. · Rigshospitalet, DBCG Secretariat, Blegdamsvej 9, DK-2100, Copenhagen, Denmark. · Mater Hospital, 25 Rocklands Road, North Sydney, NSW 2060, Australia. · University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Centre GF Leclerc, 1 Rue du Professeur Marion, 21000, Dijon, France. · Northwestern University, 633 Clark Street, Chicago, IL, 60208, USA. · Hospital Universitario Gregorio Marañón, Universidad Complutense, Ciudad Universitaria, s/n, 28040, Madrid, Spain. · Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000, Brussels, Belgium. · Sunnybrook Odette Cancer Centre, University of Toronto, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada. · Arizona Oncology, US Oncology, 3700 W. State Route 89A, Sedona, AZ, 86336, USA. · GlaxoSmithKline, 1250 S Collegeville Road, Collegeville, PA, 19426, USA. · Massachusetts General Hospital Biostatistics Center, 50 Staniford Street, Boston, MA, 02478, USA. · Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, USA. · Pubmed 25888246
  • Department of Medical Oncology, Hospital Gregorio Marañón , Madrid , Spain. · Pubmed 25851308
2014
  • Cristina Saura and Javier Cortés, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona · Jose A. Garcia-Saenz, Hospital Clinico San Carlos · Miguel Martin, Hospital Gregorio Maranon, Universidad Complutense, Madrid, Spain · Binghe Xu, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China · Wael Harb, Horizon Medical Group, Lafayette, IN · Rebecca Moroose, University of Florida Health Cancer Center, Orlando, FL · Timothy Pluard, Washington University School of Medicine, St Louis, MO · Corinne Kiger, Pfizer Global Research and Development, Paris · Caroline Germa, Novartis Pharma, Rueil-Malmaison, France · Kongming Wang, Pfizer, Pearl River · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · and Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Pubmed 25287822
  • Affiliations of authors: "Sandra Pitigliani" Medical Oncology Unit, Hospital of Prato, Prato, Italy (ADL, LM) · Medical Oncology, Centre Hospitalier Universitaire Sart Tilman and Liège University, Liège, Belgium (GJ) · Department of Oncology, First Faculty of Medicine of Charles University, Prague, Czech Republic (LP) · Clinical Oncology, Instituto Nacional del Cáncer, Santiago, Chile (RT) · Dnipropetrovsk Municipal Clinical Hospital, Dnipropetrovsk, Ukraine (INB) · Republican Clinical Oncological Center, Kazan, Russia (RK) · AZ Klina, Brasschaat, Belgium (DV) · Mastology, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil (JLP) · Thoracal Department, Medical Radiological Science Center, Obninsk, Russia (IS) · Chemotherapy and Combined Therapy, Russian Cancer Research Centre, Moscow, Russia (MRL) · Medical Oncology, Kansas City Cancer Center, Kansas City, MO USA (KP) · AstraZeneca Pharmaceuticals, Macclesfield, UK (SG, YR) · Medical Oncology Service, Instituto de Investigacion Sanitaria, Hospital Universitario Gregorio Maranon, Universidad Complutense, Madrid, Spain (MM). · Pubmed 24317176
  • Luzerner Kantonsspital, Lucerne, Switzerland; University of Berne, Berne, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland. Electronic address: · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA. · National Surgical Adjuvant Breast and Bowel Project Biostatistical Center, Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. · National Institute of Oncology, Budapest, Hungary. · Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Leids Universitair Medisch Centrum, Leiden, Netherlands. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Baylor College of Medicine, Houston, TX, USA. · Hospital Puerta Del Mar, Cádiz, Spain. · Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland; Breast Center, Kantonsspital, St Gallen, Switzerland. · Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa. · MD Anderson Cancer Center, Orlando, FL, USA. · Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · International Breast Cancer Study Group, Bern, Switzerland; University of Sydney, Sydney, Australia. · University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA. · Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · Stanford University School of Medicine, Stanford, CA, USA. · Pubmed 24439313
2013
  • Hospital Universitario Gregorio Marañón, Universidad Complutense, Calle de Maiquez 7, 28009 Madrid, Spain. · Pubmed 23953056
  • Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutense, Dr. Esquerdo 46, Madrid 28009, Spain. · Pubmed 23733779
  • Medical Oncology Service, Instituto de Investigación Sanitaria Hospital Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Pubmed 23873719
  • Gregorio Marañon Research Institute, Complutense University of Madrid, Calle del Doctor Esquerdo 46, 28007 Madrid, Spain. · Pubmed 23712182
  • Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Pubmed 23684410
  • Department of Medical Oncology, Instituto de Investigación Sanitaria Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Pubmed 23423445
2012
  • Complutense University and Hospital General Universitario Gregorio Maranon, Servicio De Oncologia Medica, Madrid, Spain. · Pubmed 22893628
2010
  • Hospital General Universitario Gregorio Marañón, Madrid, Spain. · Pubmed 21121833
  • Servicio de Oncología Médica, Departmento de Oncología, Hospital General Universitario Gregorio Marañón, 28009 Madrid, Spain. · Pubmed 20037779
2009
  • Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain. · Pubmed 19828405
2015
  • Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy. · Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy · Pubmed 25908555
2014
  • aSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA bHuman Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Center cSan Carlos University Hospital dInstitute for Health Research, University Hospital Gregorio Marañón, Madrid eUniversity Hospital Virgen de la Victoria, Malaga, Spain. · Pubmed 24595012
2012
  • Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Calle Dr Esquerdo 46, 28007, Madrid, Spain. · Pubmed 22764764
Probable:    Universidad Complutense de Madrid      
2018
  • From the University of Texas M.D. Anderson Cancer Center, Houston (J.K.L.), and the Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas (J.L.B.) - both in Texas · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (H.S.R.), and Pfizer (R.G.W.Q., D.M., I.C.T., A.L.H.), San Francisco, University of California, Los Angeles, Los Angeles (S.A.H.), and Kaiser Permanente, Northern California, Vallejo (L.F.) - all in California · the Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technische Universität München (J.E.), and Interdisziplinäres Onkologisches Zentrum München (W.E.) - both in Munich, Germany · Institut Paoli-Calmettes, Marseille (A.G.), and Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulouse (H.R.) - both in France · Seoul National University Hospital (K.-H.L.) and Samsung Medical Center (Y.-H.I.) - both in Seoul, South Korea · Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel (R.Y.) · Banner M.D. Anderson Cancer Center, Gilbert, AZ (L.A.M.) · and Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Oncología, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid (M.M.). · Pubmed 30110579
  • Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Via Suor Niccolina 20, Prato 59100, Italy. Electronic address: · CHU Sart Tilman Liège and Liège University, Avenue de L'Hôpital 1, 4000 Liège, Belgium. Electronic address: · Instituto Nacional del Cáncer, Avda Profesor Zañartu 1010, Independencia, Santiago, Región Metropolitana, Chile. Electronic address: · University of Antwerp, Prinsstraat 13, 2000 Antwerpen, Belgium. Electronic address: · University of Kansas Cancer Center, 1000 E 101st Terrace, Kansas City, MO 64131, USA. Electronic address: · Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Via Suor Niccolina 20, Prato 59100, Italy. Electronic address: · AstraZeneca, da Vinci Building, Melbourn Science Park, Melbourn, Royston, Herts, SG8 6HB, UK. Electronic address: · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CiberOnc, GEICAM, Madrid 28007, Spain. Electronic address: · Pubmed 29324303
  • Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029, Madrid, Spain. · Gregorio Marañón Health Research Institute (IISGM), Universidad Complutense, 28007, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario Ramón y Cajal, 28034, Madrid, Spain. · Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, CB1 8RN, UK. · Department of Pediatric Hemato-Oncology, Hospital Universitario La Paz, 28046, Madrid, Spain. · Pediatric Solid Tumor Laboratory, Human Genetic Department, Research Institute of Rare Diseases, Instituto de Salud Carlos III, 28220, Majadahonda, Spain. · Department of Pediatric Cardiology, Hospital Universitario La Paz, 28046, Madrid, Spain. · Medical Oncology Service, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, 28040, Madrid, Spain. · Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain. · Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, CB1 8RN, UK. · Department of Pediatrics, Universidad de Navarra, University Clinic of Navarra, 31008, Pamplona, Spain. · Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029, Madrid, Spain. · Pubmed 28913729
2017
  • Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), CiberOnc, Madrid, Spain. · Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), Universidad Complutense, CiberOnc, GEICAM, Madrid, Spain. · Pubmed 28758424
  • a Medical Oncology Department , Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) , Madrid , Spain. · b Medical Oncology Department , Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CiberOnc , Madrid , Spain. · c Instituto de Investigación Sanitaria Gregorio Maranon (IiSGM), Universidad Complutense, CiberOnc, GEICAM , Madrid , Spain. · Pubmed 28649882
  • Instituto de Investigación Sanitaria Gregorio Marañón, Grupo Español de Investigación en Cáncer de Mama (GEICAM), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Universidad Complutense, Madrid, Spain. Electronic address: · Texas Oncology, Houston, TX, USA. · Rigshospitalet, Copenhagen, Denmark. · Institut Gustave Roussy, Villejuif, France. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Aichi Cancer Center, Chikusa-ku, Nagoya, Japan. · Luisenkrankenhaus, German Breast Group Forschungs GmbH, Düsseldorf, Neulsenburg, Germany. · BC Cancer Agency, Vancouver, BC, Canada. · Guy's and St Thomas' Hospital National Health Service Foundation Trust and Biomedical Research Centre, King's College, London, UK. · Pontifical Catholic University of Rio Grande do Sul School of Medicine, Porto Alegre, Brazil. · Department of Surgery and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria. · Daily Chemotherapy Hospital, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia. · Virginia Cancer Specialists, Arlington, VA, USA. · University Hospital for Tumors, University Hospital Center "Sestre milosrdnice", Zagreb, Croatia. · Ege University Faculty of Medicine, Izmir, Turkey. · Auckland Hospital, Auckland, New Zealand. · Oncology Department, Hospital Universitario Virgen del Rocio, Seville, Spain. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Department of Oncology, Lillebaelt Hospital, Vejle, Denmark. · Oncology Institute of Vilnius University, Vilnius, Lithuania. · Breast Oncology, Saitama Cancer Center, Kita-Adachi, Japan. · Oncologianova GmbH, Recklinghausen, Germany. · Department of Medical Oncology, Amphia Hospital, Breda, Netherlands. · Department of Oncology, Christie Hospital Manchester, Manchester, UK. · Breastlink Medical Group Inc, Santa Ana, CA, USA. · University of Alberta, Department of Oncology, Cross Cancer Institute, Edmonton, AB, Canada. · Puma Biotechnology Inc, Los Angeles, CA, USA. · International Drug Development Institute, Louvain-la-Neuve, Belgium. · Breast Cancer Research Centre-Western Australia, Perth, WA, Australia; Curtin University, Perth, WA, Australia. · Pubmed 29146401
  • Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain, on behalf of GEICAM (Spanish Breast Cancer Group), Spain. · Oncology Department, Hospital Universitario Virgen de la Salud, Toledo, Spain. · Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Oncology Department, Onkologikoa, San Sebastián, Spain. · Oncology Department, Hospital General Universitario Morales Messeguer, Murcia, Spain. · Oncology Department, Corporación Sanitaria Parc Taulí, Barcelona, Spain. · Oncology Department, Complejo Hospitalario de Jaén, Jaén, Spain. · Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Oncology Department, Complejo Hospitalario Universitario de la Coruña, La Coruña, Spain. · Oncology Department, Hospital Universitario la Paz, Madrid, Spain. · Medical Oncology Department, Hospital de Santa Creu i Sant Pau, Institut de Recerca IIB Sant Pau, Barcelona, Spain. · Oncology Department, Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife, Spain. · Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain. · Oncology Department, Hospital Clinic i Provincial, Barcelona, Spain. · GEICAM headquarters, Madrid, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 28701571
  • Edith A. Perez, Mayo Clinic, Jacksonville, FL · Howard Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN · Jennifer A. Petersen, Genentech, South San Francisco, CA · Carlos Barrios, Pontifícia Universidade Católica do Rio Grande do Sul School of Medicine, Porto Alegre, Brazil · Wolfgang Eiermann, Interdisciplinary Oncology Center, Munich, Germany · Masakazu Toi, Graduate School of Medicine, Kyoto University, Kyoto, Japan · Young-Hyuck Im, Samsung Medical Centre, Seoul, Korea · Pierfranco Conte, University of Padova and Istituto Oncologico Veneto, Padova, Italy · Miguel Martin, Facultad de Medicina, Universidad Complutense, Madrid, Spain · Tadeusz Pienkowski, Postgraduate Medical Education Center, Warsaw, Poland · Xavier Pivot, University Hospital Jean Minjoz, Besançon, France · Sven Stanzel, Alexander Strasak, Monika Patre, F. Hoffmann-La Roche, Basel, Switzerland · and Paul Ellis, Guys Hospital and Sarah Cannon Research Institute, London, United Kingdom. · Pubmed 28056202
  • Department of Medical Oncology, Hospital Clínic i Provincial, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medical Oncology, Valencia University Hospital, Valencia, Spain. · University of Edinburgh Cancer, Research UK Centre, Edinburgh. · Department of Biochemistry, University of Otago, Dunedin, New Zealand. · Department of Medical Oncology, A Coruña University Hospital Complex, A Coruña, Spain. · Department of Medical Oncology, Hospital del Mar Medical Research Institute-IMIM and Pompeu Fabra University, Barcelona, Spain. · Department of Medical Oncology, Biomedical Research Institute-IMIBIC, Reina Sofía Hospital Complex, Córdoba, Spain. · Department of Medical Oncology, Consorci Sanitari de Terrassa, Barcelona, Spain. · Department of Medical Oncology, Virgen de la Salud Hospital, Toledo, Spain. · Department of Medical Oncology, Jaén Hospital Complex, Jaen, Spain. · Department of Medical Oncology, Onkologikoa, Donostia, Spain. · Department of Medical Oncology, Hospital Clínic i Provincial, Barcelona, Spain. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina. · Department of Medical Oncology, Virgen de la Victoria University Hospital, Málaga, Spain. · GEICAM (Spanish Breast Cancer Research Group), Madrid, Spain. · Academic Department of Biochemistry, Royal Marsden Foundation Trust, London, United Kingdom. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Department of Genetics, University of North Carolina, Chapel Hill, North Carolina. · Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina. · Pubmed 27903675
  • Genolier Breast Center, Clinic of Genolier, Route du Muids 3, 1272 Genolier, Switzerland. Electronic address: · Department of Senology, National Cancer Institute G. Pascale Foundation, Via Mariano Semmola, 80131 Naples, Italy. · School of Cancer Sciences, University of Birmingham, Vincent Drive, Edgbaston, B15 2TT Birmingham, United Kingdom. · Department of Surgery, Instituto Nacional de Cancerología, Av. San Fernando No. 22, Col. Sección XVI Delegación Tlalpan, 14080 Mexico City, Mexico. · División Ginecologia y Mastologia, Hospital Dr. I. Pirovano, Av Monroe 3555, 1428 Buenos Aires, Argentina. · Department of Oncoradiology, Uzsoki Teaching Hospital, Uzsoki u. 29-41, 1145 Budapest, Hungary. · Department of Oncology, Sahlgrenska Academy and University Hospital, Per Dubbsgatan 15, 413 45 Gothenburg, Sweden; Department of Oncology/Pathology, Karolinska Institutet, Karolinska Univ Hospital, Z1:00, 171 76 Stockholm, Sweden. · University of Florida Health Cancer Center at Orlando Health, 1400 S. Orange Avenue, 32806 Orlando, FL, USA. · Department of Surgery, Athens University Medical School, Iassiou Street 8, 11521 Athens, Greece. · Multidisciplinary Breast Centre and Gynaecological Oncology, UZ Leuven, Herestraat 49, 3000 Leuven, Belgium. · Department of Radiosurgery, Russian Cancer Research Center, 23 Kashirskoye Shosse, Moscow, Russia. · Department of Surgery, Institut Curie-Université Versailles-Saint-Quentin, 35 rue Dailly, 92220 Paris-Saint-Cloud, France. · Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. · Medical Affairs, Genomic Health, Quai du Sujet 10, Stockholm, Sweden. · International, Genomic Health, Quai du Sujet 10, Geneva, Switzerland. · Department of Gynaecology, Martin-Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany. · Instituto de Investigación Sanitaria Hospital Gregorio Marañón, Universidad Complutense, c/Dr Esquerdo 46, 28007 Madrid, Spain. · Pubmed 28441617
  • Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain. · Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy. · Medical Oncology Deparment, Arnau de Vilanova de Lleida Universitary Hospital, Lleida, Spain. · Medical Oncology Department, Reina Sofía University Hospital, Cordoba, Spain. · Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Universidad Complutense, Madrid, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Medical Oncology Department, Quirón Hospital, Madrid, Spain. · Master of Breast Pathology, University of Barcelona, Barcelona, Spain. · Pathology Department, Fundación Jiménez Díaz Health Research Institute (IIS-FJD), Madrid, Spain. · Medical Oncology Department, Doce de Octubre Hospital, Madrid, Spain. · Medical Oncology Department, Hospital del Mar, Barcelona, Spain. · Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain. · Medical Oncology Department, Mutua de Terrassa Hospital, Barcelona, Spain. · Spanish Breast Cancer Research Group Grupo Español de Investigación en Cáncer de Mama (GEICAM), Madrid, Spain. · Pubmed 28423537
  • Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), Madrid, Spain; Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain. · Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain; Health Research Institute Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Dpto. Ciencias Sociales de la Actividad Física y del Ocio, Facultad de Ciencias de la Actividad Física y el Deporte, Universidad Politécnica, Madrid, Spain. · Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain. · Medical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain. · Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain. · Medical Oncology Unit, Complejo Hospitalario Universitario, A Coruña, Spain. · Hematology-Oncology Department, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Valencia, Spain. · Medical Oncology Hospital Clínic and Translational Genomics and Targeted Therapeutics in Solid Tumors, Barcelona, Spain. · Medical Oncology Unit, Centro Oncológico de Galicia, A Coruña, Spain. · Medical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain. · Medical Oncology Unit, Hospital Universitario Fundación Alcorcón, Universidad Rey Juan Carlos, Madrid, Spain. · Medical Oncology Unit, Instituto de Investigación Sanitaria Aragón, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Spanish Breast Cancer Research Group (GEICAM) Headquarters, Madrid, Spain. · Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain. · Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), Madrid, Spain; Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain. Electronic address: · Pubmed 28057355
  • NRG Oncology, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Frontier Science and Technology Research Foundation, Boston, MA, USA. · NRG Oncology and Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA. · NRG Oncology and University of Florida Health Cancer Center at Orlando Health, Orlando, FL, USA. · NRG Oncology and Centre Hospitalier de l'Universite de Montreal, Montreal, QC, Canada. · GEICAM, Instituto de Investigacion SanitariaGregorio Marañon, Universidad Complutense, Madrid, Spain. · BOOG, Dutch Breast Cancer Trialists' Group, Leids Universitair Medisch Centrum, Leiden, Netherlands. · NRG Oncology and Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · NRG Oncology and Tom Baker Cancer Centre, Calgary, Alberta, Canada. · IBCSG and National Institute of Oncology, Budapest, Hungary. · IBCSG, Bern, Switzerland and University of Sydney, Sydney, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Harvard Medical School, and Frontier Science and Technology Research Foundation, Boston, MA, USA. · NRG Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · NRG Oncology and the Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA. · IBCSG, Luzerner Kantonsspital, Lucerne and University of Berne, Switzerland and Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Pubmed 27663567
2016
  • Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, C/Dr Esquerdo 46, Madrid 28009, Spain. Electronic address: · Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, C/Dr Esquerdo 46, Madrid 28009, Spain. Electronic address: · Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, C/Dr Esquerdo 46, Madrid 28009, Spain. Electronic address: · Pubmed 27326977
  • From the Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Pubmed 27249772
  • From the Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at the University of California, Los Angeles, Santa Monica (R.S.F., D.J.S.), the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco (H.S.R.), and Pfizer, La Jolla (E.G., D.R.L., S.R.) - all in California · Hospital Gregorio Maranon, Universidad Complutense, Madrid (M.M.) · U.S. Oncology Research, The Woodlands, TX (S.J.) · Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.) · British Columbia Cancer Agency, Vancouver, Canada (K.G.) · Brustzentrum der Universität München (LMU), Munich, Germany (N.H.) · State Budget Medical Institution Republican Clinical Oncology, Ufa, Russia (O.N.L.) · All-Ireland Cooperative Oncology Research Group, Dublin (J.M.W.) · M.D. Anderson Cancer Center, University of Texas, Houston (S.M.) · and Institut Curie, Paris (V.D.). · Pubmed 27959613
  • Breast Cancer Research Centre-Western Australia and Curtin University, Perth, WA, Australia. Electronic address: · Institut Gustave Roussy, Villejuif, France. · Texas Oncology, Houston, TX, USA. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Aichi Cancer Center, Chikusa-ku, Nagoya, Japan. · Auckland Hospital, Auckland, New Zealand. · Virginia Cancer Specialists, The US Oncology Network, Fairfax, VA, USA. · University Hospital For Tumors, University Hospital Center "Sestre Milosrdnice", Zagreb, Croatia. · Ege University Faculty of Medicine, Izmir, Turkey. · Luisenkrankenhaus, German Breast Group Forschungs GmbH, Düsseldorf, Neu-lsenburg, Germany. · Rigshospitalet, Copenhagen, Denmark. · BC Cancer Agency, Vancouver, BC, Canada. · Guy's and St Thomas' NHS Foundation Trust and Biomedical Research Centre, King's College London, London, UK. · Pontifical Catholic University of Rio Grande do Sul School of Medicine, Porto Alegre, Brazil. · Department of Surgery and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria. · International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium. · Alabama Oncology, Birmingham, AL, USA. · Northwest Cancer Specialists, Vancouver, VA, USA. · Utah Cancer Specialists, Salt Lake City, UT, USA. · National Hospital Organization Osaka National Hospital, Chuou-ku, Osaka, Japan. · Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Instituto Valenciano de Oncologia, València, Spain. · Hematology Oncology Associates of Treasure Coast, Port Saint Lucie, FL, USA. · South Texas Oncology and Hematology, San Antonio, TX, USA. · Magna Graecia University, Catanzaro, Italy. · Puma Biotechnology, Los Angeles, CA, USA. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, Madrid, Spain. · Pubmed 26874901
  • University of Arizona Cancer Center, Tucson, AZ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Centre Hospitalier Universitaire Brugmann, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Research UK Experimental Cancer Medicine Centres, St James's University Hospital, Leeds, UK. · Weston Park Hospital, University of Sheffield, Sheffield, UK. · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. · Center for Comprehensive Gynecology Clinic, Mannheim, Germany. · National Cancer Center Hospital, Tokyo, Japan. · Instituto de Investigación Sanitaria General Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Cross Cancer Institute, Edmonton, AB, Canada. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Lancaster Urology, Lancaster, PA, USA. · Urology Associates, Christchurch, New Zealand. · The Urology Center of Colorado, Denver, CO, USA. · Sarah Cannon Research Institute, Nashville, TN, USA. · Amgen Inc., Thousand Oaks, CA, USA. · Pubmed 26335402
  • Michael F. Press, Denice D. Tsao-Wei, Yanling Ma, Ivonne Villalobos, and Anaamika Campeau, University of Southern California Norris Comprehensive Cancer Center · Dennis J. Slamon, Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA · Nicholas Robert, Virginia Cancer Specialists/US Oncology Research Network, Fairfax, VA · Vicente Valero, The University of Texas MD Anderson Cancer Center, Houston, TX · Guido Sauter and Martina Mirlacher, University of Hamburg, Hamburg · Wolfgang Eiermann, Frauenklinik vom Roten Kreuz, Munich, Germany · Marc Buyse, Hélène Fourmanoir, and Emmanuel Quinaux, International Drug Development Institute, Louvain-la-Neuve, Belgium · Tadeusz Pienkowski, Postgraduate Medical Education Center, Warsaw, Poland · John Crown, Irish Cooperative Onoclogy Research Group, St Vincent's University Hospital, Dublin, Ireland · Miguel Martin, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain · John R. Mackey, University of Alberta · Mary-Ann Lindsay, Cancer International Research Group/Translational Research in Oncology, Edmonton, Alberta, Canada · and Valerie Bee, Cancer International Research Group/Translational Research in Oncology, Paris, France. · Pubmed 27573653
  • Center for Oncology and Hematology, Wilhelminen Hospital, Vienna, Austria. Electronic address: · Massachusetts General Hospital Biostatistics Center, Boston, MA, USA. Electronic address: · Royal Marsden Hospital, London, UK. Electronic address: · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. Electronic address: · Rigshospitalet, DBCG Secretariat, Copenhagen, Denmark. Electronic address: · Mater Hospital, North Sydney, NSW, Australia. Electronic address: · University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Centre GF Leclerc, Dijon, France. Electronic address: · Northwestern University, Chicago, IL, USA. Electronic address: · Hospital Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. Electronic address: · Massachusetts General Hospital, Boston, MA, USA. Electronic address: · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada. Electronic address: · Arizona Oncology, US Oncology, Sedona, AZ, USA. Electronic address: · GlaxoSmithKline, Collegeville, PA, USA. Electronic address: · Massachusetts General Hospital Biostatistics Center, Boston, MA, USA. Electronic address: · Massachusetts General Hospital, Boston, MA, USA. Electronic address: · Pubmed 26829011
  • Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Dr Esquerdo 46, 28007 Madrid, Spain. Electronic address: · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Dr Esquerdo 46, 28007 Madrid, Spain. · Pubmed 26617201
2015
  • Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Pubmed 26101243
  • Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Dr Esquerdo 46, Madrid, 28007, Spain. · Pubmed 26067995
  • Mater Hospital, Sydney, Australia. Electronic address: · Royal Marsden Hospital, London, UK. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, United States. · Rigshospitalet, DBCG Secretariat, Copenhagen, Denmark. · UT MD Anderson Cancer Center, Houston, TX, United States. · Centre GF Leclerc, Dijon, France. · Northwestern University, Chicago, IL, United States. · Hospital Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Massachusetts General Hospital, Boston, MA, United States. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Canada. · Arizona Oncology, US Oncology, Sedona, AZ, United States. · GlaxoSmithKline, Collegeville, PA, United States; GlaxoSmithKline, Uxbridge, UK. · Pubmed 25752740
  • Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain; · Hospital Universitario Ramón y Cajal, Madrid, Spain; · Centro Oncológico Galicia, A Coruña, Spain; · Complejo Hospitalario A Coruña (CHUAC), A Coruña, Spain; · Hospital Clínico Universitario de Valencia, Valencia, Spain; · Hospital Universitario La Paz, Madrid, Spain; · Hospital Clinic de Barcelona, Barcelona, Spain; · GEICAM (Spanish Breast Cancer Group), San Sebastián de los Reyes, Madrid, Spain; · Hospital Clínico San Carlos, Madrid, Spain; · Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain; · Hospital Universitario Virgen del Rocío, Sevilla, Spain; · Hospital General Yagüe, Burgos, Spain; · Hospital Virgen de la Salud, Toledo, Spain; · Hospital General De Hospitalet, Hospitalet de Llobregat, Barcelona, Spain; · Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)-Hospital Universitario Reina Sofía, Universidad de Córdoba, Córdoba, Spain; · Complejo Hospitalario de Pontevedra, Pontevedra, Spain. · Pubmed 25601966
  • John R. Mackey, Cross Cancer Institute · Francois Thireau and Helena Fung, Translational Research in Oncology, Edmonton · Marc Webster, Tom Baker Cancer Centre, Calgary, Alberta · Karen A. Gelmon, British Columbia Cancer Agency, Vancouver, British Columbia · Sunil Verma, Sunnybrook Health Sciences Center · Lorinda Simms, Eli Lilly, Toronto, Ontario, Canada · Manuel Ramos-Vazquez, Centro Oncológico de Galicia "José Antonio Quiroga y Piñeiro," A Coruña · Miguel Martin, Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutense, Madrid, Spain · Oleg Lipatov, Republican Clinical Oncology Dispensary, Bashkortostan Republic Ministry of Health, Ufa · Dmitriy Krasnozhon, Leningrad Regional Oncology Dispensary, Leningrad · Vladimir Semiglazov, Institute of Oncology N.N. Petrov · Alexey Manikhas, City Clinical Oncology Dispensary, St Petersburg · Vera Gorbunova, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia · Nicole McCarthy, ICON Cancer Care Wesley, Brisbane, Queensland, Australia · Gottfried E. Konecny, University of California Los Angeles, Los Angeles, CA · Roberto Hegg, Hospital Pérola Byigton Centro de Referência da Saúde da Mulher, Sao Paulo, Brazil · Dany Abi Gerges, Middle East Institute of Health, Bsalim, Lebanon · Marc Buyse, International Drug Development Institute, Louvain-la-Neuve, Belgium · and Ayman Ibrahim, ImClone Systems, Bridgewater, NJ. · Pubmed 25185099
  • Cancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Cancer Epidemiology Research Group, IIS Puerta de Hierro (IDIPHIM), Majadahonda, Madrid, Spain. · Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain; Medical Oncology Unit, Instituto De Investigación Sanitaria Gregorio Marañón/ Universidad Complutense, Madrid, Spain. · Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain. · Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain. · Medical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain. · Medical Oncology Unit, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Medical Oncology Unit, Complejo Hospitalario de Jaén, Jaén, Spain. · Medical Oncology Unit, Centro Oncológico de Galicia, A Coruña, Spain. · Medical Oncology Unit, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Medical Oncology Unit, Hospital Clinic I Provincial, Barcelona, Spain. · Medical Oncology Unit, Hospital Clínico, Valencia, Spain. · Medical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain. · Medical Oncology Unit, Fundación Hospitalaria de Alcorcón, Alcorcón, Spain. · Medical Oncology Unit, Hospital Virgen de la Salud, Toledo, Spain. · Start-up Unit, Spanish Breast Cancer Research Group (GEICAM) Headquarters, San Sebastián De Los Reyes, Madrid, Spain. · Medical Oncology Unit, Instituto De Investigación Sanitaria Gregorio Marañón/ Universidad Complutense, Madrid, Spain. · Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Epidemiology Department, Universidad Miguel Hernandez, Sant Joan d'Alacant, Spain. · Pubmed 25978407
  • Center for Oncology and Hematology, Wilhelminen Hospital, Montleartstrasse 37, Vienna, 1160, Austria. · Massachusetts General Hospital Biostatistics Center, 50 Staniford Street, Boston, MA, 02478, USA. · Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, 3410 Worth Street, Dallas, TX, 75246, USA. · Rigshospitalet, DBCG Secretariat, Blegdamsvej 9, DK-2100, Copenhagen, Denmark. · Mater Hospital, 25 Rocklands Road, North Sydney, NSW 2060, Australia. · University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Centre GF Leclerc, 1 Rue du Professeur Marion, 21000, Dijon, France. · Northwestern University, 633 Clark Street, Chicago, IL, 60208, USA. · Hospital Universitario Gregorio Marañón, Universidad Complutense, Ciudad Universitaria, s/n, 28040, Madrid, Spain. · Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000, Brussels, Belgium. · Sunnybrook Odette Cancer Centre, University of Toronto, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada. · Arizona Oncology, US Oncology, 3700 W. State Route 89A, Sedona, AZ, 86336, USA. · GlaxoSmithKline, 1250 S Collegeville Road, Collegeville, PA, 19426, USA. · Massachusetts General Hospital Biostatistics Center, 50 Staniford Street, Boston, MA, 02478, USA. · Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, USA. · Pubmed 25888246
2014
  • Cristina Saura and Javier Cortés, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona · Jose A. Garcia-Saenz, Hospital Clinico San Carlos · Miguel Martin, Hospital Gregorio Maranon, Universidad Complutense, Madrid, Spain · Binghe Xu, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China · Wael Harb, Horizon Medical Group, Lafayette, IN · Rebecca Moroose, University of Florida Health Cancer Center, Orlando, FL · Timothy Pluard, Washington University School of Medicine, St Louis, MO · Corinne Kiger, Pfizer Global Research and Development, Paris · Caroline Germa, Novartis Pharma, Rueil-Malmaison, France · Kongming Wang, Pfizer, Pearl River · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · and Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Pubmed 25287822
  • Affiliations of authors: "Sandra Pitigliani" Medical Oncology Unit, Hospital of Prato, Prato, Italy (ADL, LM) · Medical Oncology, Centre Hospitalier Universitaire Sart Tilman and Liège University, Liège, Belgium (GJ) · Department of Oncology, First Faculty of Medicine of Charles University, Prague, Czech Republic (LP) · Clinical Oncology, Instituto Nacional del Cáncer, Santiago, Chile (RT) · Dnipropetrovsk Municipal Clinical Hospital, Dnipropetrovsk, Ukraine (INB) · Republican Clinical Oncological Center, Kazan, Russia (RK) · AZ Klina, Brasschaat, Belgium (DV) · Mastology, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil (JLP) · Thoracal Department, Medical Radiological Science Center, Obninsk, Russia (IS) · Chemotherapy and Combined Therapy, Russian Cancer Research Centre, Moscow, Russia (MRL) · Medical Oncology, Kansas City Cancer Center, Kansas City, MO USA (KP) · AstraZeneca Pharmaceuticals, Macclesfield, UK (SG, YR) · Medical Oncology Service, Instituto de Investigacion Sanitaria, Hospital Universitario Gregorio Maranon, Universidad Complutense, Madrid, Spain (MM). · Pubmed 24317176
  • Luzerner Kantonsspital, Lucerne, Switzerland; University of Berne, Berne, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland. Electronic address: · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA. · National Surgical Adjuvant Breast and Bowel Project Biostatistical Center, Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. · National Institute of Oncology, Budapest, Hungary. · Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Leids Universitair Medisch Centrum, Leiden, Netherlands. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Baylor College of Medicine, Houston, TX, USA. · Hospital Puerta Del Mar, Cádiz, Spain. · Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland; Breast Center, Kantonsspital, St Gallen, Switzerland. · Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa. · MD Anderson Cancer Center, Orlando, FL, USA. · Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · International Breast Cancer Study Group, Bern, Switzerland; University of Sydney, Sydney, Australia. · University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA. · Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · Stanford University School of Medicine, Stanford, CA, USA. · Pubmed 24439313
2013
  • Hospital Universitario Gregorio Marañón, Universidad Complutense, Calle de Maiquez 7, 28009 Madrid, Spain. · Pubmed 23953056
  • Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutense, Dr. Esquerdo 46, Madrid 28009, Spain. · Pubmed 23733779
  • Medical Oncology Service, Instituto de Investigación Sanitaria Hospital Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Pubmed 23873719
  • Gregorio Marañon Research Institute, Complutense University of Madrid, Calle del Doctor Esquerdo 46, 28007 Madrid, Spain. · Pubmed 23712182
  • Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Pubmed 23684410
  • Department of Medical Oncology, Instituto de Investigación Sanitaria Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Pubmed 23423445
2012
  • Complutense University and Hospital General Universitario Gregorio Maranon, Servicio De Oncologia Medica, Madrid, Spain. · Pubmed 22893628
  • Hospital Gregorio Maraňon, Universidad Complutense, 28007 Madrid, Spain. · Pubmed 22467666
2015
  • Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy. · Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy · Pubmed 25908555
2012
  • Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Calle Dr Esquerdo 46, 28007, Madrid, Spain. · Pubmed 22764764
Probable:    Hospital Clinico San Carlos      
2017
  • Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), Madrid, Spain; Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain. · Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain; Health Research Institute Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Dpto. Ciencias Sociales de la Actividad Física y del Ocio, Facultad de Ciencias de la Actividad Física y el Deporte, Universidad Politécnica, Madrid, Spain. · Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain. · Medical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain. · Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain. · Medical Oncology Unit, Complejo Hospitalario Universitario, A Coruña, Spain. · Hematology-Oncology Department, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Valencia, Spain. · Medical Oncology Hospital Clínic and Translational Genomics and Targeted Therapeutics in Solid Tumors, Barcelona, Spain. · Medical Oncology Unit, Centro Oncológico de Galicia, A Coruña, Spain. · Medical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain. · Medical Oncology Unit, Hospital Universitario Fundación Alcorcón, Universidad Rey Juan Carlos, Madrid, Spain. · Medical Oncology Unit, Instituto de Investigación Sanitaria Aragón, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Spanish Breast Cancer Research Group (GEICAM) Headquarters, Madrid, Spain. · Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain. · Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), Madrid, Spain; Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain. Electronic address: · Pubmed 28057355
2015
  • Cancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Cancer Epidemiology Research Group, IIS Puerta de Hierro (IDIPHIM), Majadahonda, Madrid, Spain. · Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain; Medical Oncology Unit, Instituto De Investigación Sanitaria Gregorio Marañón/ Universidad Complutense, Madrid, Spain. · Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain. · Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain. · Medical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain. · Medical Oncology Unit, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Medical Oncology Unit, Complejo Hospitalario de Jaén, Jaén, Spain. · Medical Oncology Unit, Centro Oncológico de Galicia, A Coruña, Spain. · Medical Oncology Unit, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Medical Oncology Unit, Hospital Clinic I Provincial, Barcelona, Spain. · Medical Oncology Unit, Hospital Clínico, Valencia, Spain. · Medical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain. · Medical Oncology Unit, Fundación Hospitalaria de Alcorcón, Alcorcón, Spain. · Medical Oncology Unit, Hospital Virgen de la Salud, Toledo, Spain. · Start-up Unit, Spanish Breast Cancer Research Group (GEICAM) Headquarters, San Sebastián De Los Reyes, Madrid, Spain. · Medical Oncology Unit, Instituto De Investigación Sanitaria Gregorio Marañón/ Universidad Complutense, Madrid, Spain. · Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Epidemiology Department, Universidad Miguel Hernandez, Sant Joan d'Alacant, Spain. · Pubmed 25978407
  • Genentech Research and Early Development, South San Francisco, California. · AstraZeneca, Waltham, Massachusetts. · International Drug Development Institute, Louvain-la-Neuve, Belgium. · USC/Norris Comprehensive Cancer Center, Los Angeles, California. · Ventana Medical Systems, Inc., Tucson, Arizona. · Frauenklinik vom Roten Kreuz, Munich, Germany. · Maria Sklodowska-Curie (MSC) Centre, Warsaw, Poland. · Hospital Universitario San Carlos, Madrid, Spain. · Virginia Cancer Specialists/U.S. Oncology Research Network, Fairfax, Virginia. · Irish Cooperative Oncology Research Group, St. Vincent's University Hospital, Dublin, Ireland. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Cancer International Research Group/Translational Research in Oncology, Paris, France. · Department of Oncology, University of Alberta, Edmonton, Canada. · Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California. · USC/Norris Comprehensive Cancer Center, Los Angeles, California. · Pubmed 25649019
2009
  • Hospital Universitario San Carlos, Madrid E-28040, Spain. · Pubmed 19661038
  • Medical Oncology Service, Hospital Universitario San Carlos, Madrid, Spain. · Pubmed 19846970
2012
  • Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain. · Pubmed 22374418
2011
  • Department of Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain. · Pubmed 21435434
2010
  • Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain. · Pubmed 20110783
  • Medical Oncology Department, Hospital Clínico San Carlos, C/Martín Lagos s/n, 28040, Madrid, Spain. · Pubmed 20063196
2009
  • Servicio de Análisis Clínicos, Hospital Clínico San Carlos, 28040, Madrid, España. · Pubmed 20032444
  • Servicio de Oncología Médica, Hospital Universitario San Carlos, Madrid, Spain. · Pubmed 19661030
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 109 total) written by Miguel Martín about Breast Neoplasms:

  • Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation. 2018
  • First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM study. 2018
  • Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients. 2018
  • Ribociclib for the treatment of advanced hormone receptor-positive, HER2-negative breast cancer. 2017
  • Neratinib for the treatment of HER2-positive early stage breast cancer. 2017
  • Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. 2017
  • Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis. 2017
  • Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study. 2017
  • A PAM50-Based Chemoendocrine Score for Hormone Receptor-Positive Breast Cancer with an Intermediate Risk of Relapse. 2017
  • Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "El Álamo III" retrospective study. 2017
Show List of Full Article Records
Google Searches

Learn more about Miguel Martín using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Hospital General Gregorio Maranon
Universidad Complutense de Madrid
Hospital Clinico San Carlos
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Hospital General Gregorio Maranon
2018
  • From the University of Texas M.D. Anderson Cancer Center, Houston (J.K.L.), and the Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas (J.L.B.) - both in Texas · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (H.S.R.), and Pfizer (R.G.W.Q., D.M., I.C.T., A.L.H.), San Francisco, University of California, Los Angeles, Los Angeles (S.A.H.), and Kaiser Permanente, Northern California, Vallejo (L.F.) - all in California · the Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technische Universität München (J.E.), and Interdisziplinäres Onkologisches Zentrum München (W.E.) - both in Munich, Germany · Institut Paoli-Calmettes, Marseille (A.G.), and Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulouse (H.R.) - both in France · Seoul National University Hospital (K.-H.L.) and Samsung Medical Center (Y.-H.I.) - both in Seoul, South Korea · Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel (R.Y.) · Banner M.D. Anderson Cancer Center, Gilbert, AZ (L.A.M.) · and Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Oncología, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid (M.M.). · Pubmed 30110579
  • Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Via Suor Niccolina 20, Prato 59100, Italy. Electronic address: · CHU Sart Tilman Liège and Liège University, Avenue de L'Hôpital 1, 4000 Liège, Belgium. Electronic address: · Instituto Nacional del Cáncer, Avda Profesor Zañartu 1010, Independencia, Santiago, Región Metropolitana, Chile. Electronic address: · University of Antwerp, Prinsstraat 13, 2000 Antwerpen, Belgium. Electronic address: · University of Kansas Cancer Center, 1000 E 101st Terrace, Kansas City, MO 64131, USA. Electronic address: · Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Via Suor Niccolina 20, Prato 59100, Italy. Electronic address: · AstraZeneca, da Vinci Building, Melbourn Science Park, Melbourn, Royston, Herts, SG8 6HB, UK. Electronic address: · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CiberOnc, GEICAM, Madrid 28007, Spain. Electronic address: · Pubmed 29324303
  • Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029, Madrid, Spain. · Gregorio Marañón Health Research Institute (IISGM), Universidad Complutense, 28007, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario Ramón y Cajal, 28034, Madrid, Spain. · Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, CB1 8RN, UK. · Department of Pediatric Hemato-Oncology, Hospital Universitario La Paz, 28046, Madrid, Spain. · Pediatric Solid Tumor Laboratory, Human Genetic Department, Research Institute of Rare Diseases, Instituto de Salud Carlos III, 28220, Majadahonda, Spain. · Department of Pediatric Cardiology, Hospital Universitario La Paz, 28046, Madrid, Spain. · Medical Oncology Service, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, 28040, Madrid, Spain. · Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain. · Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, CB1 8RN, UK. · Department of Pediatrics, Universidad de Navarra, University Clinic of Navarra, 31008, Pamplona, Spain. · Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029, Madrid, Spain. · Pubmed 28913729
2017
  • Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), CiberOnc, Madrid, Spain. · Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), Universidad Complutense, CiberOnc, GEICAM, Madrid, Spain. · Pubmed 28758424
  • a Medical Oncology Department , Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) , Madrid , Spain. · b Medical Oncology Department , Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CiberOnc , Madrid , Spain. · c Instituto de Investigación Sanitaria Gregorio Maranon (IiSGM), Universidad Complutense, CiberOnc, GEICAM , Madrid , Spain. · Pubmed 28649882
  • Instituto de Investigación Sanitaria Gregorio Marañón, Grupo Español de Investigación en Cáncer de Mama (GEICAM), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Universidad Complutense, Madrid, Spain. Electronic address: · Texas Oncology, Houston, TX, USA. · Rigshospitalet, Copenhagen, Denmark. · Institut Gustave Roussy, Villejuif, France. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Aichi Cancer Center, Chikusa-ku, Nagoya, Japan. · Luisenkrankenhaus, German Breast Group Forschungs GmbH, Düsseldorf, Neulsenburg, Germany. · BC Cancer Agency, Vancouver, BC, Canada. · Guy's and St Thomas' Hospital National Health Service Foundation Trust and Biomedical Research Centre, King's College, London, UK. · Pontifical Catholic University of Rio Grande do Sul School of Medicine, Porto Alegre, Brazil. · Department of Surgery and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria. · Daily Chemotherapy Hospital, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia. · Virginia Cancer Specialists, Arlington, VA, USA. · University Hospital for Tumors, University Hospital Center "Sestre milosrdnice", Zagreb, Croatia. · Ege University Faculty of Medicine, Izmir, Turkey. · Auckland Hospital, Auckland, New Zealand. · Oncology Department, Hospital Universitario Virgen del Rocio, Seville, Spain. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Department of Oncology, Lillebaelt Hospital, Vejle, Denmark. · Oncology Institute of Vilnius University, Vilnius, Lithuania. · Breast Oncology, Saitama Cancer Center, Kita-Adachi, Japan. · Oncologianova GmbH, Recklinghausen, Germany. · Department of Medical Oncology, Amphia Hospital, Breda, Netherlands. · Department of Oncology, Christie Hospital Manchester, Manchester, UK. · Breastlink Medical Group Inc, Santa Ana, CA, USA. · University of Alberta, Department of Oncology, Cross Cancer Institute, Edmonton, AB, Canada. · Puma Biotechnology Inc, Los Angeles, CA, USA. · International Drug Development Institute, Louvain-la-Neuve, Belgium. · Breast Cancer Research Centre-Western Australia, Perth, WA, Australia; Curtin University, Perth, WA, Australia. · Pubmed 29146401
  • Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain, on behalf of GEICAM (Spanish Breast Cancer Group), Spain. · Oncology Department, Hospital Universitario Virgen de la Salud, Toledo, Spain. · Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Oncology Department, Onkologikoa, San Sebastián, Spain. · Oncology Department, Hospital General Universitario Morales Messeguer, Murcia, Spain. · Oncology Department, Corporación Sanitaria Parc Taulí, Barcelona, Spain. · Oncology Department, Complejo Hospitalario de Jaén, Jaén, Spain. · Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Oncology Department, Complejo Hospitalario Universitario de la Coruña, La Coruña, Spain. · Oncology Department, Hospital Universitario la Paz, Madrid, Spain. · Medical Oncology Department, Hospital de Santa Creu i Sant Pau, Institut de Recerca IIB Sant Pau, Barcelona, Spain. · Oncology Department, Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife, Spain. · Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain. · Oncology Department, Hospital Clinic i Provincial, Barcelona, Spain. · GEICAM headquarters, Madrid, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 28701571
  • Department of Medical Oncology, Hospital Clínic i Provincial, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medical Oncology, Valencia University Hospital, Valencia, Spain. · University of Edinburgh Cancer, Research UK Centre, Edinburgh. · Department of Biochemistry, University of Otago, Dunedin, New Zealand. · Department of Medical Oncology, A Coruña University Hospital Complex, A Coruña, Spain. · Department of Medical Oncology, Hospital del Mar Medical Research Institute-IMIM and Pompeu Fabra University, Barcelona, Spain. · Department of Medical Oncology, Biomedical Research Institute-IMIBIC, Reina Sofía Hospital Complex, Córdoba, Spain. · Department of Medical Oncology, Consorci Sanitari de Terrassa, Barcelona, Spain. · Department of Medical Oncology, Virgen de la Salud Hospital, Toledo, Spain. · Department of Medical Oncology, Jaén Hospital Complex, Jaen, Spain. · Department of Medical Oncology, Onkologikoa, Donostia, Spain. · Department of Medical Oncology, Hospital Clínic i Provincial, Barcelona, Spain. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina. · Department of Medical Oncology, Virgen de la Victoria University Hospital, Málaga, Spain. · GEICAM (Spanish Breast Cancer Research Group), Madrid, Spain. · Academic Department of Biochemistry, Royal Marsden Foundation Trust, London, United Kingdom. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Department of Genetics, University of North Carolina, Chapel Hill, North Carolina. · Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina. · Pubmed 27903675
  • Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid, Spain. · Spanish Breast Cancer Research Group (GEICAM), San Sebastian de los Reyes, Spain. · Instituto de Salud Carlos III, Madrid, Spain. · Servicio de Oncología Médica, Instituto Valenciano de Oncología, Valencia, Spain. · Servicio de Oncología Médica, Hospital Universitari i Politècnic La Fe, Valencia, Spain. · Servicio de Oncología Médica, Hospital de Basurto-Osakidetza, Bilbao, Spain. · Servicio de Oncología Médica, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain. · Servicio de Oncología Médica, Hospital Lozano Blesa, Zaragoza, Spain. · Servicio de Oncología Médica, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Servicio de Oncología Médica, Hospital Arnau de Vilanova, Valencia, Spain. · Sección de Oncología Médica, Complejo Universitario de Albacete, Albacete, Spain. · Servicio de Oncología Médica, Servicio de Oncología Médica, Hospital Mútua de Terrassa, Barcelona, Spain. · Servicio de Oncología Médica, Hospital de Sabadell-Consorcio Sanitario Parc Taulì de Sabadell, Barcelona, Spain. · Servicio de Oncología Médica, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Servicio de Oncología Médica, Hospital Universitario Sant Joan, Alicante, Spain. · Servicio de Oncología Médica, Hospital General Universitario de Elche, Elche, Spain. · Servicio de Oncología Médica, Hospital de Sant Pau, Barcelona, Spain. · Unitat de Consell Genetic, Institut Oncologic del Valles, Terrasa, Spain. · Unidad de Oncología, Hospital Universitario Fundación Alcorcón, Alcorcon, Madrid, Spain. · Pubmed 28985233
  • Genolier Breast Center, Clinic of Genolier, Route du Muids 3, 1272 Genolier, Switzerland. Electronic address: · Department of Senology, National Cancer Institute G. Pascale Foundation, Via Mariano Semmola, 80131 Naples, Italy. · School of Cancer Sciences, University of Birmingham, Vincent Drive, Edgbaston, B15 2TT Birmingham, United Kingdom. · Department of Surgery, Instituto Nacional de Cancerología, Av. San Fernando No. 22, Col. Sección XVI Delegación Tlalpan, 14080 Mexico City, Mexico. · División Ginecologia y Mastologia, Hospital Dr. I. Pirovano, Av Monroe 3555, 1428 Buenos Aires, Argentina. · Department of Oncoradiology, Uzsoki Teaching Hospital, Uzsoki u. 29-41, 1145 Budapest, Hungary. · Department of Oncology, Sahlgrenska Academy and University Hospital, Per Dubbsgatan 15, 413 45 Gothenburg, Sweden; Department of Oncology/Pathology, Karolinska Institutet, Karolinska Univ Hospital, Z1:00, 171 76 Stockholm, Sweden. · University of Florida Health Cancer Center at Orlando Health, 1400 S. Orange Avenue, 32806 Orlando, FL, USA. · Department of Surgery, Athens University Medical School, Iassiou Street 8, 11521 Athens, Greece. · Multidisciplinary Breast Centre and Gynaecological Oncology, UZ Leuven, Herestraat 49, 3000 Leuven, Belgium. · Department of Radiosurgery, Russian Cancer Research Center, 23 Kashirskoye Shosse, Moscow, Russia. · Department of Surgery, Institut Curie-Université Versailles-Saint-Quentin, 35 rue Dailly, 92220 Paris-Saint-Cloud, France. · Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. · Medical Affairs, Genomic Health, Quai du Sujet 10, Stockholm, Sweden. · International, Genomic Health, Quai du Sujet 10, Geneva, Switzerland. · Department of Gynaecology, Martin-Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany. · Instituto de Investigación Sanitaria Hospital Gregorio Marañón, Universidad Complutense, c/Dr Esquerdo 46, 28007 Madrid, Spain. · Pubmed 28441617
  • Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain. · Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy. · Medical Oncology Deparment, Arnau de Vilanova de Lleida Universitary Hospital, Lleida, Spain. · Medical Oncology Department, Reina Sofía University Hospital, Cordoba, Spain. · Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Universidad Complutense, Madrid, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Medical Oncology Department, Quirón Hospital, Madrid, Spain. · Master of Breast Pathology, University of Barcelona, Barcelona, Spain. · Pathology Department, Fundación Jiménez Díaz Health Research Institute (IIS-FJD), Madrid, Spain. · Medical Oncology Department, Doce de Octubre Hospital, Madrid, Spain. · Medical Oncology Department, Hospital del Mar, Barcelona, Spain. · Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain. · Medical Oncology Department, Mutua de Terrassa Hospital, Barcelona, Spain. · Spanish Breast Cancer Research Group Grupo Español de Investigación en Cáncer de Mama (GEICAM), Madrid, Spain. · Pubmed 28423537
  • Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), Madrid, Spain; Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain. · Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain; Health Research Institute Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Dpto. Ciencias Sociales de la Actividad Física y del Ocio, Facultad de Ciencias de la Actividad Física y el Deporte, Universidad Politécnica, Madrid, Spain. · Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain. · Medical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain. · Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain. · Medical Oncology Unit, Complejo Hospitalario Universitario, A Coruña, Spain. · Hematology-Oncology Department, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Valencia, Spain. · Medical Oncology Hospital Clínic and Translational Genomics and Targeted Therapeutics in Solid Tumors, Barcelona, Spain. · Medical Oncology Unit, Centro Oncológico de Galicia, A Coruña, Spain. · Medical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain. · Medical Oncology Unit, Hospital Universitario Fundación Alcorcón, Universidad Rey Juan Carlos, Madrid, Spain. · Medical Oncology Unit, Instituto de Investigación Sanitaria Aragón, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Spanish Breast Cancer Research Group (GEICAM) Headquarters, Madrid, Spain. · Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain. · Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), Madrid, Spain; Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain. Electronic address: · Pubmed 28057355
  • Hospital General Universitario Gregorio Marañon, Madrid, Spain. · Hospital Clínico San Carlos, Madrid, Spain. · Hospital Universitario Infanta Cristina, Parla, Madrid, Spain. · Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), Madrid, Spain. · Hospital General Universitario Gregorio Marañon, Madrid, Spain. · Pubmed 28040858
  • University of Kansas Medical Center, Westwood, Kansas. · Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain. · University of Kansas Medical Center, Westwood, Kansas. · Medical Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Laboratory of Translational Oncology. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Oncology Department, Hospital Clínico, Valladolid, Spain. · Department of Oncology, Ramon y Cajal University Hospital, Madrid, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. · Department of Pathology & Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. · Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Pubmed 27301700
2016
  • Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, C/Dr Esquerdo 46, Madrid 28009, Spain. Electronic address: · Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, C/Dr Esquerdo 46, Madrid 28009, Spain. Electronic address: · Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, C/Dr Esquerdo 46, Madrid 28009, Spain. Electronic address: · Pubmed 27326977
  • From the Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Pubmed 27249772
  • Dept. of Hematology and Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, "Rio Hortega Project in research training" (CM12/00264), Spain. Electronic address: · Dept. of Hematology and Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Spain. · Dept. of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain. · Dept. of Medical Oncology, Hospital Del Mar, Barcelona, Spain. · Dept. of Hematology and Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Spain. Electronic address: · Pubmed 26318092
  • From the Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at the University of California, Los Angeles, Santa Monica (R.S.F., D.J.S.), the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco (H.S.R.), and Pfizer, La Jolla (E.G., D.R.L., S.R.) - all in California · Hospital Gregorio Maranon, Universidad Complutense, Madrid (M.M.) · U.S. Oncology Research, The Woodlands, TX (S.J.) · Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.) · British Columbia Cancer Agency, Vancouver, Canada (K.G.) · Brustzentrum der Universität München (LMU), Munich, Germany (N.H.) · State Budget Medical Institution Republican Clinical Oncology, Ufa, Russia (O.N.L.) · All-Ireland Cooperative Oncology Research Group, Dublin (J.M.W.) · M.D. Anderson Cancer Center, University of Texas, Houston (S.M.) · and Institut Curie, Paris (V.D.). · Pubmed 27959613
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Hospital General Universitario and Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Hopital Sant Louis, Paris, France. · Pharma-Mar, Clinical R&D, Colmenar Viejo, Madrid, Spain. · Institut Gustave Roussy, Villejuif, France. · Pubmed 27266804
  • Department of Medical Oncology, Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutente de Madrid, Calle Maiquez 7, Madrid, Spain. · Sividon Diagnostics GmbH, Cologne, Germany. · Department of Medical Oncology, Valencian Institute of Oncology (IVO), Valencia, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medical Oncology, A Coruña University Hospital Complex, A Coruña, Spain. · Solid Tumor Molecular Diagnostics Laboratory, ARUP Laboratories, Utah, USA. · Department of Medical Oncology, Virgen del Rocio University Hospital, Seville, Spain. · Department of Medical Oncology, Salamanca University Hospital-IBSAL, Salamanca, Spain. · Department of Medical Oncology, Donostia University Hospital, Donostia, Spain. · Department of Medical Oncology, Parc Tauli University Hospital, Sabadell, Spain. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Department of Genetics, University of North Carolina, Chapel Hill, NC, USA. · Department of Pathology & Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA. · Spanish Breast Cancer Research Group (GEICAM), Madrid, Spain. · Department of Medical Oncology, Elche University General Hospital, Elche, Spain. · Pubmed 26909792
  • Breast Cancer Research Centre-Western Australia and Curtin University, Perth, WA, Australia. Electronic address: · Institut Gustave Roussy, Villejuif, France. · Texas Oncology, Houston, TX, USA. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Aichi Cancer Center, Chikusa-ku, Nagoya, Japan. · Auckland Hospital, Auckland, New Zealand. · Virginia Cancer Specialists, The US Oncology Network, Fairfax, VA, USA. · University Hospital For Tumors, University Hospital Center "Sestre Milosrdnice", Zagreb, Croatia. · Ege University Faculty of Medicine, Izmir, Turkey. · Luisenkrankenhaus, German Breast Group Forschungs GmbH, Düsseldorf, Neu-lsenburg, Germany. · Rigshospitalet, Copenhagen, Denmark. · BC Cancer Agency, Vancouver, BC, Canada. · Guy's and St Thomas' NHS Foundation Trust and Biomedical Research Centre, King's College London, London, UK. · Pontifical Catholic University of Rio Grande do Sul School of Medicine, Porto Alegre, Brazil. · Department of Surgery and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria. · International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium. · Alabama Oncology, Birmingham, AL, USA. · Northwest Cancer Specialists, Vancouver, VA, USA. · Utah Cancer Specialists, Salt Lake City, UT, USA. · National Hospital Organization Osaka National Hospital, Chuou-ku, Osaka, Japan. · Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Instituto Valenciano de Oncologia, València, Spain. · Hematology Oncology Associates of Treasure Coast, Port Saint Lucie, FL, USA. · South Texas Oncology and Hematology, San Antonio, TX, USA. · Magna Graecia University, Catanzaro, Italy. · Puma Biotechnology, Los Angeles, CA, USA. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, Madrid, Spain. · Pubmed 26874901
  • University of Arizona Cancer Center, Tucson, AZ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Centre Hospitalier Universitaire Brugmann, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Research UK Experimental Cancer Medicine Centres, St James's University Hospital, Leeds, UK. · Weston Park Hospital, University of Sheffield, Sheffield, UK. · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. · Center for Comprehensive Gynecology Clinic, Mannheim, Germany. · National Cancer Center Hospital, Tokyo, Japan. · Instituto de Investigación Sanitaria General Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Cross Cancer Institute, Edmonton, AB, Canada. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Lancaster Urology, Lancaster, PA, USA. · Urology Associates, Christchurch, New Zealand. · The Urology Center of Colorado, Denver, CO, USA. · Sarah Cannon Research Institute, Nashville, TN, USA. · Amgen Inc., Thousand Oaks, CA, USA. · Pubmed 26335402
  • Michael F. Press, Denice D. Tsao-Wei, Yanling Ma, Ivonne Villalobos, and Anaamika Campeau, University of Southern California Norris Comprehensive Cancer Center · Dennis J. Slamon, Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA · Nicholas Robert, Virginia Cancer Specialists/US Oncology Research Network, Fairfax, VA · Vicente Valero, The University of Texas MD Anderson Cancer Center, Houston, TX · Guido Sauter and Martina Mirlacher, University of Hamburg, Hamburg · Wolfgang Eiermann, Frauenklinik vom Roten Kreuz, Munich, Germany · Marc Buyse, Hélène Fourmanoir, and Emmanuel Quinaux, International Drug Development Institute, Louvain-la-Neuve, Belgium · Tadeusz Pienkowski, Postgraduate Medical Education Center, Warsaw, Poland · John Crown, Irish Cooperative Onoclogy Research Group, St Vincent's University Hospital, Dublin, Ireland · Miguel Martin, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain · John R. Mackey, University of Alberta · Mary-Ann Lindsay, Cancer International Research Group/Translational Research in Oncology, Edmonton, Alberta, Canada · and Valerie Bee, Cancer International Research Group/Translational Research in Oncology, Paris, France. · Pubmed 27573653
  • Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, Madrid, Spain. · Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, Madrid, Spain. · Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón, Madrid, Spain. · Medical Genetics Unit, Sistemas Genómicos SA, Valencia, Spain. · Medical Oncology Service, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid, Spain. · Instituto Nacional de Enfermedades Neoplásicas (I.N.E.N.), Lima, Peru. · Pubmed 27083178
  • Center for Oncology and Hematology, Wilhelminen Hospital, Vienna, Austria. Electronic address: · Massachusetts General Hospital Biostatistics Center, Boston, MA, USA. Electronic address: · Royal Marsden Hospital, London, UK. Electronic address: · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. Electronic address: · Rigshospitalet, DBCG Secretariat, Copenhagen, Denmark. Electronic address: · Mater Hospital, North Sydney, NSW, Australia. Electronic address: · University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Centre GF Leclerc, Dijon, France. Electronic address: · Northwestern University, Chicago, IL, USA. Electronic address: · Hospital Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. Electronic address: · Massachusetts General Hospital, Boston, MA, USA. Electronic address: · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada. Electronic address: · Arizona Oncology, US Oncology, Sedona, AZ, USA. Electronic address: · GlaxoSmithKline, Collegeville, PA, USA. Electronic address: · Massachusetts General Hospital Biostatistics Center, Boston, MA, USA. Electronic address: · Massachusetts General Hospital, Boston, MA, USA. Electronic address: · Pubmed 26829011
  • Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Dr Esquerdo 46, 28007 Madrid, Spain. Electronic address: · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Dr Esquerdo 46, 28007 Madrid, Spain. · Pubmed 26617201
2015
  • Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Pubmed 26101243
  • Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Dr Esquerdo 46, Madrid, 28007, Spain. · Pubmed 26067995
  • Karen A. Gelmon, David G. Huntsman, and Samuel Aparicio, British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver · Susan L. Ellard, British Columbia Cancer Agency, Cancer Centre for the Southern Interior, Kelowna, British Columbia · Julie Lemieux, Centre Hospitalier Affilié Hopital Du St Sacrement, Quebec City, Quebec · Lois E. Shepherd, Dora Nomikos, Judith-Anne W. Chapman, and Wendy R. Parulekar, NCIC Clinical Trials Group, Queen's University, Kingston · Susan Dent, Ottawa Health Research Institute, Ottawa · Kathleen I. Pritchard, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto · Timothy J. Whelan, Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario · Katia Tonkin, Cross Cancer Institute, Edmonton, Alberta, Canada · Frances M. Boyle, Patricia Ritchie Centre for Cancer Care and Research, Mater Hospital, North Sydney, New South Wales, Australia · Bella Kaufman, Sheba Medical Centre, Tel Hashomer · Shulamith Rizel, Rabin Medical Center, Petach Tikva, Israel · Alexey Manikhas, City Clinical Oncological Dispensery, St Petersburg · Sergei Tjulandin, Russian Cancer Research Center, Moscow · Rustem Khasanov, Clinical Oncology Dispensary, Kazan, Russia · Angelo Di Leo, Sandro Pitgliani Medical Oncology Unit, Prato, Italy · Miguel Martin, Servicio Oncologia Hospital Gregorio Marañon, Madrid, Spain · Lee S. Schwartzberg, West Clinic, Memphis, TN · Arnd Nusch, Praxis, Velbert, Germany · Robert E. Coleman, Weston Park Hospital, Cancer Research Centre, Sheffield, United Kingdom · Hirofumi Mukai, National Cancer Center Hospital East, Kashiwa-shi, Japan · Anne P. Connor, GlaxoSmithKline, Collegeville, PA · and Sergio L. Santillana, GlaxoSmithKline, Rio de Janeiro, Brazil. · Pubmed 25779558
  • Mater Hospital, Sydney, Australia. Electronic address: · Royal Marsden Hospital, London, UK. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, United States. · Rigshospitalet, DBCG Secretariat, Copenhagen, Denmark. · UT MD Anderson Cancer Center, Houston, TX, United States. · Centre GF Leclerc, Dijon, France. · Northwestern University, Chicago, IL, United States. · Hospital Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Massachusetts General Hospital, Boston, MA, United States. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Canada. · Arizona Oncology, US Oncology, Sedona, AZ, United States. · GlaxoSmithKline, Collegeville, PA, United States; GlaxoSmithKline, Uxbridge, UK. · Pubmed 25752740
  • Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain; · Hospital Universitario Ramón y Cajal, Madrid, Spain; · Centro Oncológico Galicia, A Coruña, Spain; · Complejo Hospitalario A Coruña (CHUAC), A Coruña, Spain; · Hospital Clínico Universitario de Valencia, Valencia, Spain; · Hospital Universitario La Paz, Madrid, Spain; · Hospital Clinic de Barcelona, Barcelona, Spain; · GEICAM (Spanish Breast Cancer Group), San Sebastián de los Reyes, Madrid, Spain; · Hospital Clínico San Carlos, Madrid, Spain; · Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain; · Hospital Universitario Virgen del Rocío, Sevilla, Spain; · Hospital General Yagüe, Burgos, Spain; · Hospital Virgen de la Salud, Toledo, Spain; · Hospital General De Hospitalet, Hospitalet de Llobregat, Barcelona, Spain; · Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)-Hospital Universitario Reina Sofía, Universidad de Córdoba, Córdoba, Spain; · Complejo Hospitalario de Pontevedra, Pontevedra, Spain. · Pubmed 25601966
  • John R. Mackey, Cross Cancer Institute · Francois Thireau and Helena Fung, Translational Research in Oncology, Edmonton · Marc Webster, Tom Baker Cancer Centre, Calgary, Alberta · Karen A. Gelmon, British Columbia Cancer Agency, Vancouver, British Columbia · Sunil Verma, Sunnybrook Health Sciences Center · Lorinda Simms, Eli Lilly, Toronto, Ontario, Canada · Manuel Ramos-Vazquez, Centro Oncológico de Galicia "José Antonio Quiroga y Piñeiro," A Coruña · Miguel Martin, Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutense, Madrid, Spain · Oleg Lipatov, Republican Clinical Oncology Dispensary, Bashkortostan Republic Ministry of Health, Ufa · Dmitriy Krasnozhon, Leningrad Regional Oncology Dispensary, Leningrad · Vladimir Semiglazov, Institute of Oncology N.N. Petrov · Alexey Manikhas, City Clinical Oncology Dispensary, St Petersburg · Vera Gorbunova, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia · Nicole McCarthy, ICON Cancer Care Wesley, Brisbane, Queensland, Australia · Gottfried E. Konecny, University of California Los Angeles, Los Angeles, CA · Roberto Hegg, Hospital Pérola Byigton Centro de Referência da Saúde da Mulher, Sao Paulo, Brazil · Dany Abi Gerges, Middle East Institute of Health, Bsalim, Lebanon · Marc Buyse, International Drug Development Institute, Louvain-la-Neuve, Belgium · and Ayman Ibrahim, ImClone Systems, Bridgewater, NJ. · Pubmed 25185099
  • Cancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Cancer Epidemiology Research Group, IIS Puerta de Hierro (IDIPHIM), Majadahonda, Madrid, Spain. · Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain; Medical Oncology Unit, Instituto De Investigación Sanitaria Gregorio Marañón/ Universidad Complutense, Madrid, Spain. · Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain. · Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain. · Medical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain. · Medical Oncology Unit, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Medical Oncology Unit, Complejo Hospitalario de Jaén, Jaén, Spain. · Medical Oncology Unit, Centro Oncológico de Galicia, A Coruña, Spain. · Medical Oncology Unit, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Medical Oncology Unit, Hospital Clinic I Provincial, Barcelona, Spain. · Medical Oncology Unit, Hospital Clínico, Valencia, Spain. · Medical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain. · Medical Oncology Unit, Fundación Hospitalaria de Alcorcón, Alcorcón, Spain. · Medical Oncology Unit, Hospital Virgen de la Salud, Toledo, Spain. · Start-up Unit, Spanish Breast Cancer Research Group (GEICAM) Headquarters, San Sebastián De Los Reyes, Madrid, Spain. · Medical Oncology Unit, Instituto De Investigación Sanitaria Gregorio Marañón/ Universidad Complutense, Madrid, Spain. · Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Epidemiology Department, Universidad Miguel Hernandez, Sant Joan d'Alacant, Spain. · Pubmed 25978407
  • Center for Oncology and Hematology, Wilhelminen Hospital, Montleartstrasse 37, Vienna, 1160, Austria. · Massachusetts General Hospital Biostatistics Center, 50 Staniford Street, Boston, MA, 02478, USA. · Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, 3410 Worth Street, Dallas, TX, 75246, USA. · Rigshospitalet, DBCG Secretariat, Blegdamsvej 9, DK-2100, Copenhagen, Denmark. · Mater Hospital, 25 Rocklands Road, North Sydney, NSW 2060, Australia. · University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Centre GF Leclerc, 1 Rue du Professeur Marion, 21000, Dijon, France. · Northwestern University, 633 Clark Street, Chicago, IL, 60208, USA. · Hospital Universitario Gregorio Marañón, Universidad Complutense, Ciudad Universitaria, s/n, 28040, Madrid, Spain. · Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000, Brussels, Belgium. · Sunnybrook Odette Cancer Centre, University of Toronto, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada. · Arizona Oncology, US Oncology, 3700 W. State Route 89A, Sedona, AZ, 86336, USA. · GlaxoSmithKline, 1250 S Collegeville Road, Collegeville, PA, 19426, USA. · Massachusetts General Hospital Biostatistics Center, 50 Staniford Street, Boston, MA, 02478, USA. · Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, USA. · Pubmed 25888246
  • Department of Medical Oncology, Hospital Gregorio Marañón , Madrid , Spain. · Pubmed 25851308
2014
  • Cristina Saura and Javier Cortés, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona · Jose A. Garcia-Saenz, Hospital Clinico San Carlos · Miguel Martin, Hospital Gregorio Maranon, Universidad Complutense, Madrid, Spain · Binghe Xu, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China · Wael Harb, Horizon Medical Group, Lafayette, IN · Rebecca Moroose, University of Florida Health Cancer Center, Orlando, FL · Timothy Pluard, Washington University School of Medicine, St Louis, MO · Corinne Kiger, Pfizer Global Research and Development, Paris · Caroline Germa, Novartis Pharma, Rueil-Malmaison, France · Kongming Wang, Pfizer, Pearl River · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · and Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Pubmed 25287822
  • Affiliations of authors: "Sandra Pitigliani" Medical Oncology Unit, Hospital of Prato, Prato, Italy (ADL, LM) · Medical Oncology, Centre Hospitalier Universitaire Sart Tilman and Liège University, Liège, Belgium (GJ) · Department of Oncology, First Faculty of Medicine of Charles University, Prague, Czech Republic (LP) · Clinical Oncology, Instituto Nacional del Cáncer, Santiago, Chile (RT) · Dnipropetrovsk Municipal Clinical Hospital, Dnipropetrovsk, Ukraine (INB) · Republican Clinical Oncological Center, Kazan, Russia (RK) · AZ Klina, Brasschaat, Belgium (DV) · Mastology, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil (JLP) · Thoracal Department, Medical Radiological Science Center, Obninsk, Russia (IS) · Chemotherapy and Combined Therapy, Russian Cancer Research Centre, Moscow, Russia (MRL) · Medical Oncology, Kansas City Cancer Center, Kansas City, MO USA (KP) · AstraZeneca Pharmaceuticals, Macclesfield, UK (SG, YR) · Medical Oncology Service, Instituto de Investigacion Sanitaria, Hospital Universitario Gregorio Maranon, Universidad Complutense, Madrid, Spain (MM). · Pubmed 24317176
  • Luzerner Kantonsspital, Lucerne, Switzerland; University of Berne, Berne, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland. Electronic address: · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA. · National Surgical Adjuvant Breast and Bowel Project Biostatistical Center, Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. · National Institute of Oncology, Budapest, Hungary. · Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Leids Universitair Medisch Centrum, Leiden, Netherlands. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Baylor College of Medicine, Houston, TX, USA. · Hospital Puerta Del Mar, Cádiz, Spain. · Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland; Breast Center, Kantonsspital, St Gallen, Switzerland. · Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa. · MD Anderson Cancer Center, Orlando, FL, USA. · Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · International Breast Cancer Study Group, Bern, Switzerland; University of Sydney, Sydney, Australia. · University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA. · Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · Stanford University School of Medicine, Stanford, CA, USA. · Pubmed 24439313
2013
  • Hospital Universitario Gregorio Marañón, Universidad Complutense, Calle de Maiquez 7, 28009 Madrid, Spain. · Pubmed 23953056
  • Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutense, Dr. Esquerdo 46, Madrid 28009, Spain. · Pubmed 23733779
  • Medical Oncology Service, Instituto de Investigación Sanitaria Hospital Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Pubmed 23873719
  • Gregorio Marañon Research Institute, Complutense University of Madrid, Calle del Doctor Esquerdo 46, 28007 Madrid, Spain. · Pubmed 23712182
  • Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Pubmed 23684410
  • Department of Medical Oncology, Instituto de Investigación Sanitaria Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Pubmed 23423445
2012
  • Complutense University and Hospital General Universitario Gregorio Maranon, Servicio De Oncologia Medica, Madrid, Spain. · Pubmed 22893628
2010
  • Hospital General Universitario Gregorio Marañón, Madrid, Spain. · Pubmed 21121833
  • Servicio de Oncología Médica, Departmento de Oncología, Hospital General Universitario Gregorio Marañón, 28009 Madrid, Spain. · Pubmed 20037779
2009
  • Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain. · Pubmed 19828405
2015
  • Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy. · Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy · Pubmed 25908555
2014
  • aSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA bHuman Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Center cSan Carlos University Hospital dInstitute for Health Research, University Hospital Gregorio Marañón, Madrid eUniversity Hospital Virgen de la Victoria, Malaga, Spain. · Pubmed 24595012
2012
  • Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Calle Dr Esquerdo 46, 28007, Madrid, Spain. · Pubmed 22764764
Universidad Complutense de Madrid
2018
  • From the University of Texas M.D. Anderson Cancer Center, Houston (J.K.L.), and the Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas (J.L.B.) - both in Texas · University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (H.S.R.), and Pfizer (R.G.W.Q., D.M., I.C.T., A.L.H.), San Francisco, University of California, Los Angeles, Los Angeles (S.A.H.), and Kaiser Permanente, Northern California, Vallejo (L.F.) - all in California · the Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technische Universität München (J.E.), and Interdisziplinäres Onkologisches Zentrum München (W.E.) - both in Munich, Germany · Institut Paoli-Calmettes, Marseille (A.G.), and Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulouse (H.R.) - both in France · Seoul National University Hospital (K.-H.L.) and Samsung Medical Center (Y.-H.I.) - both in Seoul, South Korea · Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel (R.Y.) · Banner M.D. Anderson Cancer Center, Gilbert, AZ (L.A.M.) · and Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Oncología, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid (M.M.). · Pubmed 30110579
  • Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Via Suor Niccolina 20, Prato 59100, Italy. Electronic address: · CHU Sart Tilman Liège and Liège University, Avenue de L'Hôpital 1, 4000 Liège, Belgium. Electronic address: · Instituto Nacional del Cáncer, Avda Profesor Zañartu 1010, Independencia, Santiago, Región Metropolitana, Chile. Electronic address: · University of Antwerp, Prinsstraat 13, 2000 Antwerpen, Belgium. Electronic address: · University of Kansas Cancer Center, 1000 E 101st Terrace, Kansas City, MO 64131, USA. Electronic address: · Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Via Suor Niccolina 20, Prato 59100, Italy. Electronic address: · AstraZeneca, da Vinci Building, Melbourn Science Park, Melbourn, Royston, Herts, SG8 6HB, UK. Electronic address: · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CiberOnc, GEICAM, Madrid 28007, Spain. Electronic address: · Pubmed 29324303
  • Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029, Madrid, Spain. · Gregorio Marañón Health Research Institute (IISGM), Universidad Complutense, 28007, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario Ramón y Cajal, 28034, Madrid, Spain. · Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, CB1 8RN, UK. · Department of Pediatric Hemato-Oncology, Hospital Universitario La Paz, 28046, Madrid, Spain. · Pediatric Solid Tumor Laboratory, Human Genetic Department, Research Institute of Rare Diseases, Instituto de Salud Carlos III, 28220, Majadahonda, Spain. · Department of Pediatric Cardiology, Hospital Universitario La Paz, 28046, Madrid, Spain. · Medical Oncology Service, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, 28040, Madrid, Spain. · Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain. · Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, CB1 8RN, UK. · Department of Pediatrics, Universidad de Navarra, University Clinic of Navarra, 31008, Pamplona, Spain. · Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Melchor Fernández Almagro 3, 28029, Madrid, Spain. · Pubmed 28913729
2017
  • Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), CiberOnc, Madrid, Spain. · Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), Universidad Complutense, CiberOnc, GEICAM, Madrid, Spain. · Pubmed 28758424
  • a Medical Oncology Department , Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) , Madrid , Spain. · b Medical Oncology Department , Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CiberOnc , Madrid , Spain. · c Instituto de Investigación Sanitaria Gregorio Maranon (IiSGM), Universidad Complutense, CiberOnc, GEICAM , Madrid , Spain. · Pubmed 28649882
  • Instituto de Investigación Sanitaria Gregorio Marañón, Grupo Español de Investigación en Cáncer de Mama (GEICAM), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Universidad Complutense, Madrid, Spain. Electronic address: · Texas Oncology, Houston, TX, USA. · Rigshospitalet, Copenhagen, Denmark. · Institut Gustave Roussy, Villejuif, France. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Aichi Cancer Center, Chikusa-ku, Nagoya, Japan. · Luisenkrankenhaus, German Breast Group Forschungs GmbH, Düsseldorf, Neulsenburg, Germany. · BC Cancer Agency, Vancouver, BC, Canada. · Guy's and St Thomas' Hospital National Health Service Foundation Trust and Biomedical Research Centre, King's College, London, UK. · Pontifical Catholic University of Rio Grande do Sul School of Medicine, Porto Alegre, Brazil. · Department of Surgery and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria. · Daily Chemotherapy Hospital, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia. · Virginia Cancer Specialists, Arlington, VA, USA. · University Hospital for Tumors, University Hospital Center "Sestre milosrdnice", Zagreb, Croatia. · Ege University Faculty of Medicine, Izmir, Turkey. · Auckland Hospital, Auckland, New Zealand. · Oncology Department, Hospital Universitario Virgen del Rocio, Seville, Spain. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Department of Oncology, Lillebaelt Hospital, Vejle, Denmark. · Oncology Institute of Vilnius University, Vilnius, Lithuania. · Breast Oncology, Saitama Cancer Center, Kita-Adachi, Japan. · Oncologianova GmbH, Recklinghausen, Germany. · Department of Medical Oncology, Amphia Hospital, Breda, Netherlands. · Department of Oncology, Christie Hospital Manchester, Manchester, UK. · Breastlink Medical Group Inc, Santa Ana, CA, USA. · University of Alberta, Department of Oncology, Cross Cancer Institute, Edmonton, AB, Canada. · Puma Biotechnology Inc, Los Angeles, CA, USA. · International Drug Development Institute, Louvain-la-Neuve, Belgium. · Breast Cancer Research Centre-Western Australia, Perth, WA, Australia; Curtin University, Perth, WA, Australia. · Pubmed 29146401
  • Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain, on behalf of GEICAM (Spanish Breast Cancer Group), Spain. · Oncology Department, Hospital Universitario Virgen de la Salud, Toledo, Spain. · Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Oncology Department, Onkologikoa, San Sebastián, Spain. · Oncology Department, Hospital General Universitario Morales Messeguer, Murcia, Spain. · Oncology Department, Corporación Sanitaria Parc Taulí, Barcelona, Spain. · Oncology Department, Complejo Hospitalario de Jaén, Jaén, Spain. · Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Oncology Department, Complejo Hospitalario Universitario de la Coruña, La Coruña, Spain. · Oncology Department, Hospital Universitario la Paz, Madrid, Spain. · Medical Oncology Department, Hospital de Santa Creu i Sant Pau, Institut de Recerca IIB Sant Pau, Barcelona, Spain. · Oncology Department, Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife, Spain. · Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain. · Oncology Department, Hospital Clinic i Provincial, Barcelona, Spain. · GEICAM headquarters, Madrid, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 28701571
  • Edith A. Perez, Mayo Clinic, Jacksonville, FL · Howard Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN · Jennifer A. Petersen, Genentech, South San Francisco, CA · Carlos Barrios, Pontifícia Universidade Católica do Rio Grande do Sul School of Medicine, Porto Alegre, Brazil · Wolfgang Eiermann, Interdisciplinary Oncology Center, Munich, Germany · Masakazu Toi, Graduate School of Medicine, Kyoto University, Kyoto, Japan · Young-Hyuck Im, Samsung Medical Centre, Seoul, Korea · Pierfranco Conte, University of Padova and Istituto Oncologico Veneto, Padova, Italy · Miguel Martin, Facultad de Medicina, Universidad Complutense, Madrid, Spain · Tadeusz Pienkowski, Postgraduate Medical Education Center, Warsaw, Poland · Xavier Pivot, University Hospital Jean Minjoz, Besançon, France · Sven Stanzel, Alexander Strasak, Monika Patre, F. Hoffmann-La Roche, Basel, Switzerland · and Paul Ellis, Guys Hospital and Sarah Cannon Research Institute, London, United Kingdom. · Pubmed 28056202
  • Department of Medical Oncology, Hospital Clínic i Provincial, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medical Oncology, Valencia University Hospital, Valencia, Spain. · University of Edinburgh Cancer, Research UK Centre, Edinburgh. · Department of Biochemistry, University of Otago, Dunedin, New Zealand. · Department of Medical Oncology, A Coruña University Hospital Complex, A Coruña, Spain. · Department of Medical Oncology, Hospital del Mar Medical Research Institute-IMIM and Pompeu Fabra University, Barcelona, Spain. · Department of Medical Oncology, Biomedical Research Institute-IMIBIC, Reina Sofía Hospital Complex, Córdoba, Spain. · Department of Medical Oncology, Consorci Sanitari de Terrassa, Barcelona, Spain. · Department of Medical Oncology, Virgen de la Salud Hospital, Toledo, Spain. · Department of Medical Oncology, Jaén Hospital Complex, Jaen, Spain. · Department of Medical Oncology, Onkologikoa, Donostia, Spain. · Department of Medical Oncology, Hospital Clínic i Provincial, Barcelona, Spain. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina. · Department of Medical Oncology, Virgen de la Victoria University Hospital, Málaga, Spain. · GEICAM (Spanish Breast Cancer Research Group), Madrid, Spain. · Academic Department of Biochemistry, Royal Marsden Foundation Trust, London, United Kingdom. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Department of Genetics, University of North Carolina, Chapel Hill, North Carolina. · Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina. · Pubmed 27903675
  • Genolier Breast Center, Clinic of Genolier, Route du Muids 3, 1272 Genolier, Switzerland. Electronic address: · Department of Senology, National Cancer Institute G. Pascale Foundation, Via Mariano Semmola, 80131 Naples, Italy. · School of Cancer Sciences, University of Birmingham, Vincent Drive, Edgbaston, B15 2TT Birmingham, United Kingdom. · Department of Surgery, Instituto Nacional de Cancerología, Av. San Fernando No. 22, Col. Sección XVI Delegación Tlalpan, 14080 Mexico City, Mexico. · División Ginecologia y Mastologia, Hospital Dr. I. Pirovano, Av Monroe 3555, 1428 Buenos Aires, Argentina. · Department of Oncoradiology, Uzsoki Teaching Hospital, Uzsoki u. 29-41, 1145 Budapest, Hungary. · Department of Oncology, Sahlgrenska Academy and University Hospital, Per Dubbsgatan 15, 413 45 Gothenburg, Sweden; Department of Oncology/Pathology, Karolinska Institutet, Karolinska Univ Hospital, Z1:00, 171 76 Stockholm, Sweden. · University of Florida Health Cancer Center at Orlando Health, 1400 S. Orange Avenue, 32806 Orlando, FL, USA. · Department of Surgery, Athens University Medical School, Iassiou Street 8, 11521 Athens, Greece. · Multidisciplinary Breast Centre and Gynaecological Oncology, UZ Leuven, Herestraat 49, 3000 Leuven, Belgium. · Department of Radiosurgery, Russian Cancer Research Center, 23 Kashirskoye Shosse, Moscow, Russia. · Department of Surgery, Institut Curie-Université Versailles-Saint-Quentin, 35 rue Dailly, 92220 Paris-Saint-Cloud, France. · Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. · Medical Affairs, Genomic Health, Quai du Sujet 10, Stockholm, Sweden. · International, Genomic Health, Quai du Sujet 10, Geneva, Switzerland. · Department of Gynaecology, Martin-Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle (Saale), Germany. · Instituto de Investigación Sanitaria Hospital Gregorio Marañón, Universidad Complutense, c/Dr Esquerdo 46, 28007 Madrid, Spain. · Pubmed 28441617
  • Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain. · Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy. · Medical Oncology Deparment, Arnau de Vilanova de Lleida Universitary Hospital, Lleida, Spain. · Medical Oncology Department, Reina Sofía University Hospital, Cordoba, Spain. · Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Universidad Complutense, Madrid, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Medical Oncology Department, Quirón Hospital, Madrid, Spain. · Master of Breast Pathology, University of Barcelona, Barcelona, Spain. · Pathology Department, Fundación Jiménez Díaz Health Research Institute (IIS-FJD), Madrid, Spain. · Medical Oncology Department, Doce de Octubre Hospital, Madrid, Spain. · Medical Oncology Department, Hospital del Mar, Barcelona, Spain. · Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain. · Medical Oncology Department, Mutua de Terrassa Hospital, Barcelona, Spain. · Spanish Breast Cancer Research Group Grupo Español de Investigación en Cáncer de Mama (GEICAM), Madrid, Spain. · Pubmed 28423537
  • Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), Madrid, Spain; Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain. · Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain; Health Research Institute Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Dpto. Ciencias Sociales de la Actividad Física y del Ocio, Facultad de Ciencias de la Actividad Física y el Deporte, Universidad Politécnica, Madrid, Spain. · Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain. · Medical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain. · Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain. · Medical Oncology Unit, Complejo Hospitalario Universitario, A Coruña, Spain. · Hematology-Oncology Department, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Valencia, Spain. · Medical Oncology Hospital Clínic and Translational Genomics and Targeted Therapeutics in Solid Tumors, Barcelona, Spain. · Medical Oncology Unit, Centro Oncológico de Galicia, A Coruña, Spain. · Medical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain. · Medical Oncology Unit, Hospital Universitario Fundación Alcorcón, Universidad Rey Juan Carlos, Madrid, Spain. · Medical Oncology Unit, Instituto de Investigación Sanitaria Aragón, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Spanish Breast Cancer Research Group (GEICAM) Headquarters, Madrid, Spain. · Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain. · Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), Madrid, Spain; Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain. Electronic address: · Pubmed 28057355
  • NRG Oncology, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Frontier Science and Technology Research Foundation, Boston, MA, USA. · NRG Oncology and Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA. · NRG Oncology and University of Florida Health Cancer Center at Orlando Health, Orlando, FL, USA. · NRG Oncology and Centre Hospitalier de l'Universite de Montreal, Montreal, QC, Canada. · GEICAM, Instituto de Investigacion SanitariaGregorio Marañon, Universidad Complutense, Madrid, Spain. · BOOG, Dutch Breast Cancer Trialists' Group, Leids Universitair Medisch Centrum, Leiden, Netherlands. · NRG Oncology and Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · NRG Oncology and Tom Baker Cancer Centre, Calgary, Alberta, Canada. · IBCSG and National Institute of Oncology, Budapest, Hungary. · IBCSG, Bern, Switzerland and University of Sydney, Sydney, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Harvard Medical School, and Frontier Science and Technology Research Foundation, Boston, MA, USA. · NRG Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · NRG Oncology and the Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA. · IBCSG, Luzerner Kantonsspital, Lucerne and University of Berne, Switzerland and Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Pubmed 27663567
2016
  • Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, C/Dr Esquerdo 46, Madrid 28009, Spain. Electronic address: · Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, C/Dr Esquerdo 46, Madrid 28009, Spain. Electronic address: · Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, C/Dr Esquerdo 46, Madrid 28009, Spain. Electronic address: · Pubmed 27326977
  • From the Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Pubmed 27249772
  • From the Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at the University of California, Los Angeles, Santa Monica (R.S.F., D.J.S.), the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco (H.S.R.), and Pfizer, La Jolla (E.G., D.R.L., S.R.) - all in California · Hospital Gregorio Maranon, Universidad Complutense, Madrid (M.M.) · U.S. Oncology Research, The Woodlands, TX (S.J.) · Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.) · British Columbia Cancer Agency, Vancouver, Canada (K.G.) · Brustzentrum der Universität München (LMU), Munich, Germany (N.H.) · State Budget Medical Institution Republican Clinical Oncology, Ufa, Russia (O.N.L.) · All-Ireland Cooperative Oncology Research Group, Dublin (J.M.W.) · M.D. Anderson Cancer Center, University of Texas, Houston (S.M.) · and Institut Curie, Paris (V.D.). · Pubmed 27959613
  • Breast Cancer Research Centre-Western Australia and Curtin University, Perth, WA, Australia. Electronic address: · Institut Gustave Roussy, Villejuif, France. · Texas Oncology, Houston, TX, USA. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Aichi Cancer Center, Chikusa-ku, Nagoya, Japan. · Auckland Hospital, Auckland, New Zealand. · Virginia Cancer Specialists, The US Oncology Network, Fairfax, VA, USA. · University Hospital For Tumors, University Hospital Center "Sestre Milosrdnice", Zagreb, Croatia. · Ege University Faculty of Medicine, Izmir, Turkey. · Luisenkrankenhaus, German Breast Group Forschungs GmbH, Düsseldorf, Neu-lsenburg, Germany. · Rigshospitalet, Copenhagen, Denmark. · BC Cancer Agency, Vancouver, BC, Canada. · Guy's and St Thomas' NHS Foundation Trust and Biomedical Research Centre, King's College London, London, UK. · Pontifical Catholic University of Rio Grande do Sul School of Medicine, Porto Alegre, Brazil. · Department of Surgery and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria. · International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium. · Alabama Oncology, Birmingham, AL, USA. · Northwest Cancer Specialists, Vancouver, VA, USA. · Utah Cancer Specialists, Salt Lake City, UT, USA. · National Hospital Organization Osaka National Hospital, Chuou-ku, Osaka, Japan. · Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Instituto Valenciano de Oncologia, València, Spain. · Hematology Oncology Associates of Treasure Coast, Port Saint Lucie, FL, USA. · South Texas Oncology and Hematology, San Antonio, TX, USA. · Magna Graecia University, Catanzaro, Italy. · Puma Biotechnology, Los Angeles, CA, USA. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, Madrid, Spain. · Pubmed 26874901
  • University of Arizona Cancer Center, Tucson, AZ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Centre Hospitalier Universitaire Brugmann, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Research UK Experimental Cancer Medicine Centres, St James's University Hospital, Leeds, UK. · Weston Park Hospital, University of Sheffield, Sheffield, UK. · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. · Center for Comprehensive Gynecology Clinic, Mannheim, Germany. · National Cancer Center Hospital, Tokyo, Japan. · Instituto de Investigación Sanitaria General Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Cross Cancer Institute, Edmonton, AB, Canada. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Lancaster Urology, Lancaster, PA, USA. · Urology Associates, Christchurch, New Zealand. · The Urology Center of Colorado, Denver, CO, USA. · Sarah Cannon Research Institute, Nashville, TN, USA. · Amgen Inc., Thousand Oaks, CA, USA. · Pubmed 26335402
  • Michael F. Press, Denice D. Tsao-Wei, Yanling Ma, Ivonne Villalobos, and Anaamika Campeau, University of Southern California Norris Comprehensive Cancer Center · Dennis J. Slamon, Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA · Nicholas Robert, Virginia Cancer Specialists/US Oncology Research Network, Fairfax, VA · Vicente Valero, The University of Texas MD Anderson Cancer Center, Houston, TX · Guido Sauter and Martina Mirlacher, University of Hamburg, Hamburg · Wolfgang Eiermann, Frauenklinik vom Roten Kreuz, Munich, Germany · Marc Buyse, Hélène Fourmanoir, and Emmanuel Quinaux, International Drug Development Institute, Louvain-la-Neuve, Belgium · Tadeusz Pienkowski, Postgraduate Medical Education Center, Warsaw, Poland · John Crown, Irish Cooperative Onoclogy Research Group, St Vincent's University Hospital, Dublin, Ireland · Miguel Martin, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain · John R. Mackey, University of Alberta · Mary-Ann Lindsay, Cancer International Research Group/Translational Research in Oncology, Edmonton, Alberta, Canada · and Valerie Bee, Cancer International Research Group/Translational Research in Oncology, Paris, France. · Pubmed 27573653
  • Center for Oncology and Hematology, Wilhelminen Hospital, Vienna, Austria. Electronic address: · Massachusetts General Hospital Biostatistics Center, Boston, MA, USA. Electronic address: · Royal Marsden Hospital, London, UK. Electronic address: · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. Electronic address: · Rigshospitalet, DBCG Secretariat, Copenhagen, Denmark. Electronic address: · Mater Hospital, North Sydney, NSW, Australia. Electronic address: · University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Centre GF Leclerc, Dijon, France. Electronic address: · Northwestern University, Chicago, IL, USA. Electronic address: · Hospital Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. Electronic address: · Massachusetts General Hospital, Boston, MA, USA. Electronic address: · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada. Electronic address: · Arizona Oncology, US Oncology, Sedona, AZ, USA. Electronic address: · GlaxoSmithKline, Collegeville, PA, USA. Electronic address: · Massachusetts General Hospital Biostatistics Center, Boston, MA, USA. Electronic address: · Massachusetts General Hospital, Boston, MA, USA. Electronic address: · Pubmed 26829011
  • Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Dr Esquerdo 46, 28007 Madrid, Spain. Electronic address: · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Dr Esquerdo 46, 28007 Madrid, Spain. · Pubmed 26617201
2015
  • Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Pubmed 26101243
  • Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Dr Esquerdo 46, Madrid, 28007, Spain. · Pubmed 26067995
  • Mater Hospital, Sydney, Australia. Electronic address: · Royal Marsden Hospital, London, UK. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, United States. · Rigshospitalet, DBCG Secretariat, Copenhagen, Denmark. · UT MD Anderson Cancer Center, Houston, TX, United States. · Centre GF Leclerc, Dijon, France. · Northwestern University, Chicago, IL, United States. · Hospital Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Massachusetts General Hospital, Boston, MA, United States. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Canada. · Arizona Oncology, US Oncology, Sedona, AZ, United States. · GlaxoSmithKline, Collegeville, PA, United States; GlaxoSmithKline, Uxbridge, UK. · Pubmed 25752740
  • Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain; · Hospital Universitario Ramón y Cajal, Madrid, Spain; · Centro Oncológico Galicia, A Coruña, Spain; · Complejo Hospitalario A Coruña (CHUAC), A Coruña, Spain; · Hospital Clínico Universitario de Valencia, Valencia, Spain; · Hospital Universitario La Paz, Madrid, Spain; · Hospital Clinic de Barcelona, Barcelona, Spain; · GEICAM (Spanish Breast Cancer Group), San Sebastián de los Reyes, Madrid, Spain; · Hospital Clínico San Carlos, Madrid, Spain; · Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain; · Hospital Universitario Virgen del Rocío, Sevilla, Spain; · Hospital General Yagüe, Burgos, Spain; · Hospital Virgen de la Salud, Toledo, Spain; · Hospital General De Hospitalet, Hospitalet de Llobregat, Barcelona, Spain; · Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)-Hospital Universitario Reina Sofía, Universidad de Córdoba, Córdoba, Spain; · Complejo Hospitalario de Pontevedra, Pontevedra, Spain. · Pubmed 25601966
  • John R. Mackey, Cross Cancer Institute · Francois Thireau and Helena Fung, Translational Research in Oncology, Edmonton · Marc Webster, Tom Baker Cancer Centre, Calgary, Alberta · Karen A. Gelmon, British Columbia Cancer Agency, Vancouver, British Columbia · Sunil Verma, Sunnybrook Health Sciences Center · Lorinda Simms, Eli Lilly, Toronto, Ontario, Canada · Manuel Ramos-Vazquez, Centro Oncológico de Galicia "José Antonio Quiroga y Piñeiro," A Coruña · Miguel Martin, Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutense, Madrid, Spain · Oleg Lipatov, Republican Clinical Oncology Dispensary, Bashkortostan Republic Ministry of Health, Ufa · Dmitriy Krasnozhon, Leningrad Regional Oncology Dispensary, Leningrad · Vladimir Semiglazov, Institute of Oncology N.N. Petrov · Alexey Manikhas, City Clinical Oncology Dispensary, St Petersburg · Vera Gorbunova, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia · Nicole McCarthy, ICON Cancer Care Wesley, Brisbane, Queensland, Australia · Gottfried E. Konecny, University of California Los Angeles, Los Angeles, CA · Roberto Hegg, Hospital Pérola Byigton Centro de Referência da Saúde da Mulher, Sao Paulo, Brazil · Dany Abi Gerges, Middle East Institute of Health, Bsalim, Lebanon · Marc Buyse, International Drug Development Institute, Louvain-la-Neuve, Belgium · and Ayman Ibrahim, ImClone Systems, Bridgewater, NJ. · Pubmed 25185099
  • Cancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Cancer Epidemiology Research Group, IIS Puerta de Hierro (IDIPHIM), Majadahonda, Madrid, Spain. · Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain; Medical Oncology Unit, Instituto De Investigación Sanitaria Gregorio Marañón/ Universidad Complutense, Madrid, Spain. · Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain. · Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain. · Medical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain. · Medical Oncology Unit, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Medical Oncology Unit, Complejo Hospitalario de Jaén, Jaén, Spain. · Medical Oncology Unit, Centro Oncológico de Galicia, A Coruña, Spain. · Medical Oncology Unit, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Medical Oncology Unit, Hospital Clinic I Provincial, Barcelona, Spain. · Medical Oncology Unit, Hospital Clínico, Valencia, Spain. · Medical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain. · Medical Oncology Unit, Fundación Hospitalaria de Alcorcón, Alcorcón, Spain. · Medical Oncology Unit, Hospital Virgen de la Salud, Toledo, Spain. · Start-up Unit, Spanish Breast Cancer Research Group (GEICAM) Headquarters, San Sebastián De Los Reyes, Madrid, Spain. · Medical Oncology Unit, Instituto De Investigación Sanitaria Gregorio Marañón/ Universidad Complutense, Madrid, Spain. · Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Epidemiology Department, Universidad Miguel Hernandez, Sant Joan d'Alacant, Spain. · Pubmed 25978407
  • Center for Oncology and Hematology, Wilhelminen Hospital, Montleartstrasse 37, Vienna, 1160, Austria. · Massachusetts General Hospital Biostatistics Center, 50 Staniford Street, Boston, MA, 02478, USA. · Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, 3410 Worth Street, Dallas, TX, 75246, USA. · Rigshospitalet, DBCG Secretariat, Blegdamsvej 9, DK-2100, Copenhagen, Denmark. · Mater Hospital, 25 Rocklands Road, North Sydney, NSW 2060, Australia. · University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Centre GF Leclerc, 1 Rue du Professeur Marion, 21000, Dijon, France. · Northwestern University, 633 Clark Street, Chicago, IL, 60208, USA. · Hospital Universitario Gregorio Marañón, Universidad Complutense, Ciudad Universitaria, s/n, 28040, Madrid, Spain. · Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000, Brussels, Belgium. · Sunnybrook Odette Cancer Centre, University of Toronto, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada. · Arizona Oncology, US Oncology, 3700 W. State Route 89A, Sedona, AZ, 86336, USA. · GlaxoSmithKline, 1250 S Collegeville Road, Collegeville, PA, 19426, USA. · Massachusetts General Hospital Biostatistics Center, 50 Staniford Street, Boston, MA, 02478, USA. · Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, USA. · Pubmed 25888246
2014
  • Cristina Saura and Javier Cortés, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona · Jose A. Garcia-Saenz, Hospital Clinico San Carlos · Miguel Martin, Hospital Gregorio Maranon, Universidad Complutense, Madrid, Spain · Binghe Xu, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China · Wael Harb, Horizon Medical Group, Lafayette, IN · Rebecca Moroose, University of Florida Health Cancer Center, Orlando, FL · Timothy Pluard, Washington University School of Medicine, St Louis, MO · Corinne Kiger, Pfizer Global Research and Development, Paris · Caroline Germa, Novartis Pharma, Rueil-Malmaison, France · Kongming Wang, Pfizer, Pearl River · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · and Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Pubmed 25287822
  • Affiliations of authors: "Sandra Pitigliani" Medical Oncology Unit, Hospital of Prato, Prato, Italy (ADL, LM) · Medical Oncology, Centre Hospitalier Universitaire Sart Tilman and Liège University, Liège, Belgium (GJ) · Department of Oncology, First Faculty of Medicine of Charles University, Prague, Czech Republic (LP) · Clinical Oncology, Instituto Nacional del Cáncer, Santiago, Chile (RT) · Dnipropetrovsk Municipal Clinical Hospital, Dnipropetrovsk, Ukraine (INB) · Republican Clinical Oncological Center, Kazan, Russia (RK) · AZ Klina, Brasschaat, Belgium (DV) · Mastology, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil (JLP) · Thoracal Department, Medical Radiological Science Center, Obninsk, Russia (IS) · Chemotherapy and Combined Therapy, Russian Cancer Research Centre, Moscow, Russia (MRL) · Medical Oncology, Kansas City Cancer Center, Kansas City, MO USA (KP) · AstraZeneca Pharmaceuticals, Macclesfield, UK (SG, YR) · Medical Oncology Service, Instituto de Investigacion Sanitaria, Hospital Universitario Gregorio Maranon, Universidad Complutense, Madrid, Spain (MM). · Pubmed 24317176
  • Luzerner Kantonsspital, Lucerne, Switzerland; University of Berne, Berne, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland. Electronic address: · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA. · National Surgical Adjuvant Breast and Bowel Project Biostatistical Center, Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. · National Institute of Oncology, Budapest, Hungary. · Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Leids Universitair Medisch Centrum, Leiden, Netherlands. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Baylor College of Medicine, Houston, TX, USA. · Hospital Puerta Del Mar, Cádiz, Spain. · Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland; Breast Center, Kantonsspital, St Gallen, Switzerland. · Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa. · MD Anderson Cancer Center, Orlando, FL, USA. · Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · International Breast Cancer Study Group, Bern, Switzerland; University of Sydney, Sydney, Australia. · University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA. · Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · Stanford University School of Medicine, Stanford, CA, USA. · Pubmed 24439313
2013
  • Hospital Universitario Gregorio Marañón, Universidad Complutense, Calle de Maiquez 7, 28009 Madrid, Spain. · Pubmed 23953056
  • Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutense, Dr. Esquerdo 46, Madrid 28009, Spain. · Pubmed 23733779
  • Medical Oncology Service, Instituto de Investigación Sanitaria Hospital Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Pubmed 23873719
  • Gregorio Marañon Research Institute, Complutense University of Madrid, Calle del Doctor Esquerdo 46, 28007 Madrid, Spain. · Pubmed 23712182
  • Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Pubmed 23684410
  • Department of Medical Oncology, Instituto de Investigación Sanitaria Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Pubmed 23423445
2012
  • Complutense University and Hospital General Universitario Gregorio Maranon, Servicio De Oncologia Medica, Madrid, Spain. · Pubmed 22893628
  • Hospital Gregorio Maraňon, Universidad Complutense, 28007 Madrid, Spain. · Pubmed 22467666
2015
  • Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy. · Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy · Pubmed 25908555
2012
  • Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Calle Dr Esquerdo 46, 28007, Madrid, Spain. · Pubmed 22764764
Hospital Clinico San Carlos
2017
  • Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), Madrid, Spain; Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain. · Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain; Health Research Institute Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Dpto. Ciencias Sociales de la Actividad Física y del Ocio, Facultad de Ciencias de la Actividad Física y el Deporte, Universidad Politécnica, Madrid, Spain. · Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain. · Medical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain. · Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain. · Medical Oncology Unit, Complejo Hospitalario Universitario, A Coruña, Spain. · Hematology-Oncology Department, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Valencia, Spain. · Medical Oncology Hospital Clínic and Translational Genomics and Targeted Therapeutics in Solid Tumors, Barcelona, Spain. · Medical Oncology Unit, Centro Oncológico de Galicia, A Coruña, Spain. · Medical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain. · Medical Oncology Unit, Hospital Universitario Fundación Alcorcón, Universidad Rey Juan Carlos, Madrid, Spain. · Medical Oncology Unit, Instituto de Investigación Sanitaria Aragón, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Spanish Breast Cancer Research Group (GEICAM) Headquarters, Madrid, Spain. · Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain. · Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), Madrid, Spain; Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain. Electronic address: · Pubmed 28057355
2015
  • Cancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Cancer Epidemiology Research Group, IIS Puerta de Hierro (IDIPHIM), Majadahonda, Madrid, Spain. · Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain; Medical Oncology Unit, Instituto De Investigación Sanitaria Gregorio Marañón/ Universidad Complutense, Madrid, Spain. · Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain. · Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain. · Medical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain. · Medical Oncology Unit, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Medical Oncology Unit, Complejo Hospitalario de Jaén, Jaén, Spain. · Medical Oncology Unit, Centro Oncológico de Galicia, A Coruña, Spain. · Medical Oncology Unit, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Medical Oncology Unit, Hospital Clinic I Provincial, Barcelona, Spain. · Medical Oncology Unit, Hospital Clínico, Valencia, Spain. · Medical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain. · Medical Oncology Unit, Fundación Hospitalaria de Alcorcón, Alcorcón, Spain. · Medical Oncology Unit, Hospital Virgen de la Salud, Toledo, Spain. · Start-up Unit, Spanish Breast Cancer Research Group (GEICAM) Headquarters, San Sebastián De Los Reyes, Madrid, Spain. · Medical Oncology Unit, Instituto De Investigación Sanitaria Gregorio Marañón/ Universidad Complutense, Madrid, Spain. · Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Epidemiology Department, Universidad Miguel Hernandez, Sant Joan d'Alacant, Spain. · Pubmed 25978407
  • Genentech Research and Early Development, South San Francisco, California. · AstraZeneca, Waltham, Massachusetts. · International Drug Development Institute, Louvain-la-Neuve, Belgium. · USC/Norris Comprehensive Cancer Center, Los Angeles, California. · Ventana Medical Systems, Inc., Tucson, Arizona. · Frauenklinik vom Roten Kreuz, Munich, Germany. · Maria Sklodowska-Curie (MSC) Centre, Warsaw, Poland. · Hospital Universitario San Carlos, Madrid, Spain. · Virginia Cancer Specialists/U.S. Oncology Research Network, Fairfax, Virginia. · Irish Cooperative Oncology Research Group, St. Vincent's University Hospital, Dublin, Ireland. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Cancer International Research Group/Translational Research in Oncology, Paris, France. · Department of Oncology, University of Alberta, Edmonton, Canada. · Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California. · USC/Norris Comprehensive Cancer Center, Los Angeles, California. · Pubmed 25649019
2009
  • Hospital Universitario San Carlos, Madrid E-28040, Spain. · Pubmed 19661038
  • Medical Oncology Service, Hospital Universitario San Carlos, Madrid, Spain. · Pubmed 19846970
2012
  • Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain. · Pubmed 22374418
2011
  • Department of Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain. · Pubmed 21435434
2010
  • Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain. · Pubmed 20110783
  • Medical Oncology Department, Hospital Clínico San Carlos, C/Martín Lagos s/n, 28040, Madrid, Spain. · Pubmed 20063196
2009
  • Servicio de Análisis Clínicos, Hospital Clínico San Carlos, 28040, Madrid, España. · Pubmed 20032444
  • Servicio de Oncología Médica, Hospital Universitario San Carlos, Madrid, Spain. · Pubmed 19661030
Miscellaneous cities in Spain
2017
  • Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain, on behalf of GEICAM (Spanish Breast Cancer Group), Spain. · Oncology Department, Hospital Universitario Virgen de la Salud, Toledo, Spain. · Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Oncology Department, Onkologikoa, San Sebastián, Spain. · Oncology Department, Hospital General Universitario Morales Messeguer, Murcia, Spain. · Oncology Department, Corporación Sanitaria Parc Taulí, Barcelona, Spain. · Oncology Department, Complejo Hospitalario de Jaén, Jaén, Spain. · Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Oncology Department, Complejo Hospitalario Universitario de la Coruña, La Coruña, Spain. · Oncology Department, Hospital Universitario la Paz, Madrid, Spain. · Medical Oncology Department, Hospital de Santa Creu i Sant Pau, Institut de Recerca IIB Sant Pau, Barcelona, Spain. · Oncology Department, Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife, Spain. · Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain. · Oncology Department, Hospital Clinic i Provincial, Barcelona, Spain. · GEICAM headquarters, Madrid, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Pubmed 28701571
2012
  • Medical Oncology Service, Biomedical Research Institute, Arnau de Vilanova University Hospital, Lleida, Spain. · Pubmed 21717449
University of Kansas School of Medicine
2017
  • University of Kansas Medical Center, Westwood, Kansas. · Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain. · University of Kansas Medical Center, Westwood, Kansas. · Medical Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Laboratory of Translational Oncology. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Oncology Department, Hospital Clínico, Valladolid, Spain. · Department of Oncology, Ramon y Cajal University Hospital, Madrid, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. · Department of Pathology & Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. · Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Pubmed 27301700
Miscellaneous institutions in San Sebastian
2017
  • Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid, Spain. · Spanish Breast Cancer Research Group (GEICAM), San Sebastian de los Reyes, Spain. · Instituto de Salud Carlos III, Madrid, Spain. · Servicio de Oncología Médica, Instituto Valenciano de Oncología, Valencia, Spain. · Servicio de Oncología Médica, Hospital Universitari i Politècnic La Fe, Valencia, Spain. · Servicio de Oncología Médica, Hospital de Basurto-Osakidetza, Bilbao, Spain. · Servicio de Oncología Médica, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain. · Servicio de Oncología Médica, Hospital Lozano Blesa, Zaragoza, Spain. · Servicio de Oncología Médica, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Servicio de Oncología Médica, Hospital Arnau de Vilanova, Valencia, Spain. · Sección de Oncología Médica, Complejo Universitario de Albacete, Albacete, Spain. · Servicio de Oncología Médica, Servicio de Oncología Médica, Hospital Mútua de Terrassa, Barcelona, Spain. · Servicio de Oncología Médica, Hospital de Sabadell-Consorcio Sanitario Parc Taulì de Sabadell, Barcelona, Spain. · Servicio de Oncología Médica, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Servicio de Oncología Médica, Hospital Universitario Sant Joan, Alicante, Spain. · Servicio de Oncología Médica, Hospital General Universitario de Elche, Elche, Spain. · Servicio de Oncología Médica, Hospital de Sant Pau, Barcelona, Spain. · Unitat de Consell Genetic, Institut Oncologic del Valles, Terrasa, Spain. · Unidad de Oncología, Hospital Universitario Fundación Alcorcón, Alcorcon, Madrid, Spain. · Pubmed 28985233
Unspecified
2015
  • Miguel Martín, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense · Carlos Jara, Fundación Hospitalaria de Alcorcón · Noelia Martínez-Jáñez, Hospital Universitario Ramón y Cajal · César Mendiola Fernández, Hospital Universitario · Ana Isabel Ballesteros, Hospital de la Princesa · Maribel Casas, María del Carmen Cámara, and Eva Carrasco, GEICAM Headquarters, Madrid · Amparo Ruiz Simón, Instituto Valenciano de Oncología · Ana Santaballa, Hospital Universitario La Fe · Ana Lluch, Hospital Clínico Universitario de Valencia-INCLIVA-Universidad de Valencia, Valencia · Manuel Ruiz Borrego, Hospital Universitario Virgen del Rocío, Sevilla · Nuria Ribelles, Hospital Universitario Virgen de la Victoria IBIMA, Málaga · Álvaro Rodríguez-Lescure, Hospital General de Elche · Encarna Adrover, Hospital Clínico Universitario de Alicante, Alicante · Montserrat Muñoz-Mateu, Hospital Clinic i Provincial · Sonia González, Hospital Mutua de Terrassa · Mireia Margelí Vila, Hospital Universitario Germans Trias i Pujol · Agustí Barnadas, Universitat Autònoma de Barcelona, Barcelona · Manuel Ramos, Centro Oncológico de Galicia · Lourdes Calvo, Complejo Hospitalario Universitario A Coruña, A Coruã · Sonia Del Barco Berron, Instituto Catalán de Oncología, Girona · César A. Rodríguez, Hospital Universitario de Salamanca, Salamanca, Spain · Eduardo Martínez de Dueñas, Hospital Provincial de Castellón, Castellón · Raquel Andrés, Hospital Universitario Lozano Blesa, Zaragoza · Arrate Plazaola, Onkologikoa, San Sebastián · Juan de la Haba-Rodríguez, Universidad de Córdoba, Córdoba · Jose Manuel López-Vega, Hospital Universitario Marqués de Valdecilla, Santander · Pedro Sánchez-Rovira, Complejo Hospitalario de Jaén, Jaén · and José M. Baena-Cañada, Hospital Universitario Puerta del Mar, Cádiz, Spain. · Pubmed 26416999
2015
  • Miguel Martín, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense · Noelia Martinez, University Hospital Ramón y Cajal · José Ángel Garcia-Saenz, University Hospital Clínico San Carlos · Eva Carrasco, Grupo Español de Investigación en Cáncer de Mama, Madrid · Serafín Morales, Hospital Arnau de Vilanova de Lérida, Lérida · Angel Guerrero, Valencian Institute of Oncology, Valencia · Antonio Anton, University Hospital Miguel Servet, Zaragoza · Montserrat Muñoz, University Hospital Clinic i Provincial · Mireia Margeli, Hospital Universitario Germans Trias i Pujol, Barcelona · Miguel Gil, Catalan Institute of Oncology, Hospitalet · Manuel Ramos, Centro Oncológico de Galicia, La Coruña · Juan R. De la Haba-Rodriguez, Instituto Maimonides de Investigación Biomédica de Córdoba (IMIBIC) -Hospital Universitario Reina Sofía, Universidad de Córdoba, Córdoba, Spain · Sibylle Loibl, Gunter von Minckwitz, and Keyur Mehta, German Breast Group, Neu-Isenburg · Sibylle Loibl, Gunter von Minckwitz, and Keyur Mehta, Sana Klinikum Offenbach, Offenbach · Bahriye Aktas, University Women's Hospital Essen, Essen · Winfried Schoenegg, Medical Practice Berlin, Berlin · Cornelia Liedtke, University Women's Hospital Münster, Münster · Cornelia Liedtke, University Hospital Lübeck, Lübeck · and Grischa Wachsmann, Klinikum Böblingen, Böblingen, Germany. · Pubmed 25691671
2013
  • AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK. · Pubmed 23378064
2012
Miscellaneous institutions in Madrid
2011
  • Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain. · Pubmed 21429799
2016
  • Medical Oncology Department, MD Anderson Cancer Center, Madrid, C/ Arturo Soria, 270, 28033 - Madrid. Spain. · Pubmed 26278712
2015
  • Miguel Martín, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense · Noelia Martinez, University Hospital Ramón y Cajal · José Ángel Garcia-Saenz, University Hospital Clínico San Carlos · Eva Carrasco, Grupo Español de Investigación en Cáncer de Mama, Madrid · Serafín Morales, Hospital Arnau de Vilanova de Lérida, Lérida · Angel Guerrero, Valencian Institute of Oncology, Valencia · Antonio Anton, University Hospital Miguel Servet, Zaragoza · Montserrat Muñoz, University Hospital Clinic i Provincial · Mireia Margeli, Hospital Universitario Germans Trias i Pujol, Barcelona · Miguel Gil, Catalan Institute of Oncology, Hospitalet · Manuel Ramos, Centro Oncológico de Galicia, La Coruña · Juan R. De la Haba-Rodriguez, Instituto Maimonides de Investigación Biomédica de Córdoba (IMIBIC) -Hospital Universitario Reina Sofía, Universidad de Córdoba, Córdoba, Spain · Sibylle Loibl, Gunter von Minckwitz, and Keyur Mehta, German Breast Group, Neu-Isenburg · Sibylle Loibl, Gunter von Minckwitz, and Keyur Mehta, Sana Klinikum Offenbach, Offenbach · Bahriye Aktas, University Women's Hospital Essen, Essen · Winfried Schoenegg, Medical Practice Berlin, Berlin · Cornelia Liedtke, University Women's Hospital Münster, Münster · Cornelia Liedtke, University Hospital Lübeck, Lübeck · and Grischa Wachsmann, Klinikum Böblingen, Böblingen, Germany. · Pubmed 25691671
  • Physical Activity and Sport Science Faculty, Technical University of Madrid, Calle Martín Fierro, 7, C.P.: 28040, Madrid, Spain, · Pubmed 26293147
2011
  • Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid, Spain. · Pubmed 21325291
45 Other Locations Show
Yearly article counts 313141451712131170
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.